Exploring two-dimensional chromatography and chemiluminescence selectivity for complex sample analysis by Holland, Brendan John
 
 
 
 
 
 
 
 
Exploring Two-Dimensional Chromatography and 
Chemiluminescence Selectivity for Complex Sample 
Analysis  
 
 
 
 
 
by 
 
 
Brendan John Holland 
BSc (Hons) 
 
 
 
 
 
 
Submitted in fulfilment of the requirements for the degree of 
Doctor of Philosophy  
 
 
 
 
 
 
 
Deakin University 
 
April, 2015
 
DEAKIN UNIVERSITY 
ACCESS TO THESIS - A 
Deakin University CRICOS Provider Code 00113B 
 
  
I am the author of the thesis entitled: 
 
Exploring Two-Dimensional Chromatography and 
Chemiluminescence Selectivity for Complex Sample Analysis  
 
 
submitted for the degree of Doctor of Philosophy 
 
 
 
 
 
This thesis may be made available for consultation, loan and limited copying in 
accordance with the Copyright Act 1968.  
 
 
 
 
 
 
 
 
 
 
 
 
I certify that I am the student named below and that the information provided in 
the form is correct 
 
 
Full Name: .........Brendan John Holland………….…………………..                      
   (Please Print) 
Signed: ............ ....................................…… 
Date: .................24 April 2015.......................…….…….…….……….
 
DEAKIN UNIVERSITY 
CANDIDATE DECLARATION 
Deakin University CRICOS Provider Code 00113B 
 
 
I certify the following about the thesis entitled:  
  
Exploring Two-Dimensional Chromatography and 
Chemiluminescence Selectivity for Complex Sample Analysis  
submitted for the degree of Doctor of Philosophy 
 
a. I am the creator of all or part of the whole work(s) (including content and 
layout) and that where reference is made to the work of others, due 
acknowledgment is given. 
 
b. The work(s) are not in any way a violation or infringement of any 
copyright, trademark, patent, or other rights whatsoever of any person. 
 
c. That if the work(s) have been commissioned, sponsored or supported by 
any organisation, I have fulfilled all of the obligations required by such 
contract or agreement. 
 
I also certify that any material in the thesis which has been accepted for a degree 
or diploma by any university or institution is identified in the text. 
 
 
'I certify that I am the student named below and that the information provided in 
the form is correct' 
 
Full Name: .........Brendan John Holland…………….……………….. 
   (Please Print) 
Signed: ............ .......…….………………… 
Date: .................24 April 2015............................…….…….……
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“You done good mate” 
 
െ Anonymous 
 
 
 
 
 
Table of Contents 
iii 
 
Contents 
Acknowledgements ..............................................................................................vii 
Publications ........................................................................................................... ix 
Abstract ................................................................................................................. xi 
Chapter One ........................................................................................................... 1 
1. Chemically complex sample matrices ..................................................... 1 
 Background ........................................................................................... 1 
 Analysing neurotransmitters in chemically complex samples of human 
and animal origin ......................................................................................... 2 
1.2.1 Neurotransmitters in the brain ........................................................ 3 
1.2.2 Neurotransmitter metabolites in urine ............................................ 4 
 Coffee: a chemically complex sample of plant origin .......................... 4 
 Preparation of complex samples for analysis ....................................... 5 
 Sample dimensionality in complex samples ......................................... 6 
2. Finding the components of chemically complex samples: 
chemiluminescence detection .......................................................................... 7 
 General principles of chemiluminescence ............................................ 7 
 Acidic potassium permanganate as a chemiluminescence reagent ...... 8 
 Enhancing the selectivity and sensitivity of permanganate 
chemiluminescence ................................................................................... 10 
3. Separating chemically complex samples: high performance liquid 
chromatography ............................................................................................. 12 
 One dimensional high performance liquid chromatography .............. 12 
 Two-dimensional high performance liquid chromatography 
(2D- HPLC) ............................................................................................... 12 
 Assessing the performance of 2D-HPLC: theory ............................... 13 
3.3.1. Calculating spreading angle via a geometric approach to factor 
analysis (GAFA) .................................................................................... 15 
3.3.2. Calculating fractional surface coverage using the bins method .. 16 
 Overcoming solvent mismatch in 2D-HPLC ..................................... 17 
 In-silico chromatography modelling using DryLab® ........................ 19 
4. Project Aims .......................................................................................... 21 
Chapter Two ........................................................................................................ 23 
1. Chromatographic techniques ................................................................. 23 
 High performance liquid chromatography ......................................... 23 
 Ion chromatography ............................................................................ 25 
Table of Contents 
iv 
 
2. Chemiluminescence instrumentation .................................................... 26 
 Flow injection analysis ....................................................................... 26 
 Sequential injection analysis .............................................................. 27 
3. Phosphorus-31 nuclear magnetic resonance spectroscopy .................... 28 
Chapter Three ...................................................................................................... 29 
1. Introduction ........................................................................................... 29 
2. Experimental ......................................................................................... 33 
 Chemicals and reagents ...................................................................... 33 
 31P NMR ............................................................................................. 34 
 Modified end group titration .............................................................. 35 
 Flow injection analysis (FIA) ............................................................. 36 
 Ion chromatography ............................................................................ 37 
 Ion chromatography × inductively coupled plasma-mass spectrometry 
 ......  ............................................................................................................ 37 
 Spectrophotometric monitoring .......................................................... 38 
 Sequential injection analysis (SIA) .................................................... 38 
3. Results and Discussion .......................................................................... 40 
 Characterisation of polyphosphate samples according to average chain 
length ......................................................................................................... 40 
 The influence of average polyphosphate chain length on 
permanganate chemiluminescence intensity ............................................. 44 
 Polyphosphate oligomer distribution and its influence on 
permanganate chemiluminescence intensity ............................................. 45 
 The changing retention behaviour of polyphosphate oligomers in the 
presence of Mn(II) ..................................................................................... 49 
 The relationship between polyphosphate chain length and 
concentration for optimal enhancement .................................................... 52 
 Chain length dependent polyphosphate stability ................................ 54 
 The dependence of reagent stability on polyphosphate chain length 
and concentration ...................................................................................... 55 
4. Conclusions ........................................................................................... 62 
Chapter Four ....................................................................................................... 64 
1. Introduction ........................................................................................... 64 
2. Experimental ......................................................................................... 66 
 Solvents and standards ....................................................................... 66 
 Flow injection analysis (FIA) ............................................................. 66 
 HPLC .................................................................................................. 67 
Table of Contents 
v 
 
 2D-HPLC ............................................................................................ 68 
 Preparation of rat brain ....................................................................... 71 
 Preparation of human urine ................................................................ 72 
 Acidic potassium permanganate reagent ............................................ 72 
3. Results and Discussion .......................................................................... 73 
 Development of a separation for rat brain samples ............................ 73 
 Acidic potassium permanganate reagent optimisation for 
neurotransmitter detection ......................................................................... 76 
 Determination of catecholamine neurotransmitters in brain samples 79 
 Development of a separation for neurotransmitter metabolites in urine 
 ......  ............................................................................................................ 80 
 Analysis of urine using 2D-HPLC, method 1: sample characterisation . 
 ......  ............................................................................................................ 85 
 Analysis of urine using 2D-HPLC, method 2: neurotransmitter 
metabolites ................................................................................................. 89 
4. Conclusions ........................................................................................... 92 
Chapter Five ........................................................................................................ 94 
1. Introduction ........................................................................................... 94 
2. Experimental ......................................................................................... 97 
 Chemicals and reagents ...................................................................... 97 
 Sample preparation ............................................................................. 97 
 HPLC .................................................................................................. 98 
3. Results and Discussion ........................................................................ 101 
 Using polar solutes to overcome solvent mismatch ......................... 101 
 Mixing injection plugs with polar solvents to overcome solvent 
mismatch ................................................................................................. 103 
 Operational parameters for temperature programmed HPLC .......... 104 
 Optimising the temperature gradient rate ......................................... 106 
 Developing a two-dimensional method for separation of the standard 
mixture ..................................................................................................... 110 
 Adaption of the two- dimensional method for a real sample separation 
 ......  .......................................................................................................... 113 
4. Conclusions ......................................................................................... 124 
Chapter Six ........................................................................................................ 126 
1. Introduction ......................................................................................... 126 
2. Experimental ....................................................................................... 129 
 Chemicals and reagents .................................................................... 129 
Table of Contents 
vi 
 
 Urine sample preparation ................................................................. 129 
 HPLC instrumentation ...................................................................... 130 
 HPLC columns ................................................................................. 130 
 HPLC simulation protocol ................................................................ 131 
 One-dimensional HPLC methods ..................................................... 132 
 Two-dimensional HPLC methods .................................................... 132 
3. Results and Discussion ........................................................................ 134 
 Stationary phase screening using a human urine sample matrix ...... 134 
 Determination of the stationary phase pair with the highest 
orthogonality ........................................................................................... 136 
 Coupling the selected stationary phases for 2D-HPLC .................... 138 
 A comparison of in silico 2D-HPLC method development using a 
sample vs. standards ................................................................................ 144 
4. Conclusions ......................................................................................... 145 
Chapter Seven .................................................................................................... 147 
References .......................................................................................................... 150 
 
Acknowledgements 
vii 
 
Acknowledgements 
PhD’s don’t just happen. They are a journey we embark on over mountains, 
through green pastures and across barren landscapes where green grass is a myth. 
Nonetheless, we cross the finish line with the guidance of our remarkable support 
crews. To Dr. Xavier Conlan, thank you for your time, support and patience in 
influencing me every step of the way with both this thesis and the countless other 
things I have sought your assistance with. 
Dr. Paul Stevenson, you have been a great support in driving a significant 
amount of the work presented in this thesis and providing invaluable guidance from 
the day you joined us at Deakin. Your friendship is also greatly valued. Thank you. 
Associate Professor Paul Francis, to you I also wish pay a huge thanks for your 
very significant contribution and input to my time at Deakin, especially or the 
polyphosphates work and the accolades that has yielded for me.  
To Professor Neil Barnett, you have truly provided great guidance, support 
and friendship right from second year. I owe to you my more developed food and 
wine palate, which have done exceptionally good under your guidance. I also thank 
you for a newfound low tolerance of duplicated words duplicated in sentences. Also 
to Dr. Jacqui Adcock, thank you for your guidance in setting the foundations for a 
lot of the work presented in this thesis and your direction in preparing publications. 
To my friends and colleagues at Deakin, especially Polly. One can only 
ponder on what you did wrong to have me bestowed upon you as a housemate, 
colleague and friend for the last four years? But seriously thanks for always being 
there as a listening ear or ride home when I’ve needed it. Likewise to Kirsteen, Zoe, 
Dani, Christine, Natalie, Dave, Teo and Kim (and Polly-gon!), you have been 
Acknowledgements 
viii 
 
valued friends and supporters in all aspects of my PhD. Thanks for the lunchtime 
hangouts and great adventures we’ve had around the state. 
A big thank you also to Professor José Ignacio Garciá Alonso, it has been a 
pleasure becoming accustomed to your Spanish ways and I hope we can work 
together again soon. I learnt so much from you in your short time here at Deakin. 
Thank you to Donna Edwards for your photography expertise. 
To the undergraduates I have had the pleasure to lecture and demonstrate 
to, you have provided welcome breaks from the office and afforded me with an 
outlet to teach, something I have always enjoyed doing. Special mentions to Bell, 
Cassandra, Ella and Gem for your ongoing friendships. To my friends from the 
Rotaract Club of Barwon, especially Liz, Highton Bowls Club, Gateways Support 
Services and Rotary Club of Geelong East for your support and friendships outside 
of the university. A special thanks also to you all for being concerned and coming 
to my aid after the great face plant of 2014. To Aaron and Tessa, thanks for being 
great friends and aiding my acquaintance with relaxing places like Little Creatures, 
the beach and the pub. To Mark, thanks for all the nerdy chats, new TV shows, 
cooking tips and different views; you have been a valued friend since the days of 
second year. 
A special thank you to the Australian Government for the Australian 
Postgraduate Award and Deakin University for the financial support to undertake 
this PhD. 
Finally to my family Dad, Mum, Ash and Tanya and my wonderful 
grandparents. I know you haven’t much idea about what I do but your support has 
never wavered, nurturing and inspiring me to achieve a lot of great things.  
“I love teamwork. I love the idea of everyone rallying together to help me 
win.” ― Jarod Kintz 
Publications 
ix 
 
Publications 
Listed below are references to publications that have resulted from the work 
presented in this thesis. 
1. Brendan J. Holland, Xavier A. Conlan, Paul G. Stevenson, Susannah 
Tye, Ashlie Reker, Neil W. Barnett, Jacqui L. Adcock, J and Paul S. 
Francis, ‘Determination of neurotransmitters and their metabolites using 
one- and two-dimensional liquid chromatography with acidic potassium 
permanganate chemiluminescence detection’, Analytical and 
Bioanalytical Chemistry, 406 (2014) 5669-5676. 
This paper is a result of the work presented in Chapter Four of this thesis. 
 
2. Brendan J. Holland, Jacqui L. Adcock, Pavel N. Nesterenko, Anton 
Peristyy, Paul G. Stevenson, Neil W. Barnett, Xavier A. Conlan and Paul 
S. Francis, ‘The importance of chain length for the polyphosphate 
enhancement of acidic potassium permanganate chemiluminescence’, 
Analytica Chimica Acta, 842 (2014) 35-41. 
This paper received the Original Research Publication Award from the Royal 
Australian Chemical Institute, Analytical & Environmental Chemistry Division at 
its 2014 Research & Development Topics Conference for the best student 
publication. 
This paper is a result of the work presented in Chapter Three of this thesis. 
 
3. Danielle N. Bassanese*, Brendan J. Holland*, Xavier A. Conlan, Paul S. 
Francis, Neil W. Barnett, and Paul G. Stevenson, ‘Protocols for finding 
Publications 
x 
 
the most orthogonal dimensions for two-dimensional high performance 
liquid chromatography’, Talanta, 134 (2015) 402-408. 
*Co-first authors 
This paper is a result of the work presented in Chapter Six of this thesis. 
 
4. Brendan J. Holland, Xavier A. Conlan, Paul S. Francis, Neil W. Barnett 
and Paul G. Stevenson, ‘Using temperature programming to overcome 
performance limiting solvent mismatch in two-dimensional reversed phase 
high performance liquid chromatography’, Submitted August 2015 to 
Analytical Methods. 
This submitted paper represents the work presented in Chapter Five of this 
thesis. 
 
Personal contributions to other publications during this candidature: 
1. Jessica Pandohee, Brendan J. Holland, Bingshan Li, Takuya Tsuzuki, Paul 
G. Stevenson, Neil W. Barnett, James R. Pearson, Oliver A.H. Jones and 
Xavier A. Conlan, ‘Screening of cannabinoids in industrial-grade hemp 
using two-dimensional liquid chromatography coupled with acidic 
potassium permanganate chemiluminescence detection’, Journal of 
Separation Science, 38 (2015) 2024-2032. 
Experimental guidance was provided in the optimisation of acidic potassium 
permanganate chemiluminescence for the detection of cannabinoids in hemp 
using knowledge from Chapters Three and Four of this thesis. 
 
 
Abstract 
xi 
 
Abstract 
An ever increasing necessity for the analytical scientist to decipher the most 
chemically complex of sample matrices continues the push to improve the tools and 
stratagem employed for analysis. Many important advances in the biotechnology 
and the life sciences to date owe credit to evolutions in analytical chemistry. The 
work presented in this thesis expands analytical capability and scientific 
understanding by increasing the applicability of potassium permanganate 
chemiluminescence detection; providing more advanced methodology for the 
determination of neurotransmitters and their metabolites; and presenting new 
approaches for overcoming limitations in the performance and development of two-
dimensional high performance liquid chromatography separations.  
Sodium polyphosphate is commonly used to enhance chemiluminescence 
reactions with acidic potassium permanganate up to 50-fold, but commercially 
available polyphosphates vary greatly in composition. This work has examined the 
influence of polyphosphate composition and concentration on both the dual 
enhancement mechanism of chemiluminescence intensity and the stability of the 
reagent under analytically useful conditions. A number of commercially available 
polyphosphate mixtures were characterised according to average chain length (n) 
using titration and 31P NMR methodology. The n value provides a convenient 
characterisation, but materials with similar n values can exhibit both markedly 
different distributions of phosphate oligomers and degrees of enhancement. Whilst 
there is a minimum polyphosphate chain length (n ൒ 7) required for a large 
enhancement of the emission intensity, no further advantage was obtained using 
mixtures with greater proportions of long chain oligomers. Inductively coupled 
Abstract 
xii 
 
plasma-mass spectrometry was used in attempt to identify the oligomers which 
form complexes with manganese(II), however the complexity of the mixtures did 
not enable for any positive identifications to occur. Providing there is a sufficient 
average chain length, the optimum concentration of polyphosphate is dependent on 
the analyte and in some cases may be lower than the quantities previously used in 
routine detection. However, the concentration of polyphosphate should not be 
lowered in permanganate reagents that have been partially reduced to form high 
concentrations of the key manganese(III) co-reactant, as this intermediate needs to 
be stabilised to prevent formation of insoluble manganese(IV). 
Neurotransmitters and their metabolites are key markers in the diagnosis 
and monitoring of disease, however samples of biological origin are very complex, 
demanding high capacity analytical separations. High performance liquid 
chromatography (HPLC) with chemiluminescence detection based on the reaction 
with acidic potassium permanganate and formaldehyde was explored for the 
determination of neurotransmitters and their metabolites. The neurotransmitters 
norepinephrine and dopamine were quantified in the left and right hemispheres of 
rat hippocampus, nucleus accumbens and prefrontal cortex; and the metabolites 
vanillylmandelic acid, 3,4-dihydrophenylacetic acid, 5-hydroxyindole-3-acetic 
acid and homovanillic acid were identified in human urine. Under optimised 
chemiluminescence reagent conditions the limits of detection for these analytes 
ranged from 2.5 × 10−8 to 2.5 × 10−7 M. For the determination of neurotransmitter 
metabolites in urine, two-dimensional high performance liquid chromatography 
(2D-HPLC) was employed to overcome the peak capacity limitations of the one-
dimensional separation. Two alternative 2D-HPLC separations operated in heart-
cutting mode were developed, the first with a run time of 5 hours enabled 
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characterisation of the whole sample. The second focussed on the metabolites of 
interest which allowed for a reduction in the analysis time comparable to that of 
one-dimensional HPLC whilst maintaining superior peak capacity. The methods 
developed are suitable for adaption applications involving diagnosis and 
monitoring of diseases for which levels of neurotransmitters and their metabolites 
provide important clinical information. 
Three strategies previously employed for one-dimensional HPLC were 
explored to overcome solvent mismatch between alternate 2D-HPLC separation 
dimensions, a common performance reducing limitation of this analytical 
technique. Polar solutes and solvents were mixed with a simulated first dimension 
fraction containing a high organic composition, however provided only a minimal 
improvement in peak shape when injected into a second dimension of weak mobile 
phase content. Alternatively, a 2D-HPLC that used an isocratic mobile phase and 
temperature programming for the first dimension proved effective. Temperature 
programming was utilised to manipulate solvent elution strength in place of a 
mobile phase gradient, which ensured all eluent fractions transferred into the 
second dimension were of an identical solvent composition. The outcome was an 
improvement in the peak capacity and sensitivity of the separation. When applied 
to a coffee extract used to represent a complex natural product the separation was 
completed in 35 min, had an orthogonality of 35% (calculated using the bins 
method) and a spreading angle of 52° as determined via a Geometric Approach to 
Factor Analysis. This approach of utilising a temperature gradient in the first 
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dimension compared favourably to previously reported 2D-HPLC separations of 
coffee with similar or shorter analysis times.  
The selection of two HPLC columns with vastly different retention 
mechanisms is vital for performing effective two-dimensional analyses. A 
systematic approach was taken to select a pair of HPLC columns that provide the 
most different separations for a given sample. This was completed with the aid of 
a HPLC simulator DryLab® which was able to predict retention profiles on the 
basis of real experimental data. However this was a complex task as the contents of 
sample matrix was largely unknown and peaks from the same compounds had to 
be first matched between training chromatograms to compare the retention profiles. 
A chemically complex sample matrix of urine was employed to optimise the 
column selections. Seven peaks were confidently matched between chromatograms 
by comparing relative peak areas of two detection strategies: UV absorbance and 
potassium permanganate chemiluminescence. It was found that the optimal 
combinations had a predicted orthogonality of 35% while the actual value was 
closer to 30%. This approach was compared to a second method which utilised a 
series of 17 antioxidants as an analogue for a coffee extract. The predicted 
orthogonality of this method at 39% was closer to the value of 38% obtained from 
the coffee sample.  
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Chapter One 
 
Introduction 
1. Chemically complex sample matrices 
  Background 
 Today’s analytical problems are creating an ever increasing demand for 
methods to examine more chemically complex samples than ever before from 
biological, environmental and food based origins [1]. Samples of biological origin 
for instance are analysed for numerous applications including forensic analysis, 
patient diagnosis and monitoring or pure research [2]. Examples of biological 
samples used in these applications include tissue, muscle, plant mass, body fluids, 
body waste products and hair [2]. Often the target analytes in a biological sample 
must be found at minute concentrations among a vast array of low molecular 
weight compounds and biomolecules including proteins, carbohydrates, nucleic 
acids and secondary metabolites [1, 2]. Furthermore, each application demands 
reproducible and cost effective analytical techniques that are selective and 
sensitive towards particular analytes, or capable of screening whole samples 
without an elaborate sample preparation procedure. Often the most useful 
analytical techniques are developed with the properties and constituents of a target 
sample in mind, in order to provide the information relevant to the desired 
outcomes of the analysis.  
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  Analysing neurotransmitters in chemically complex samples of 
human and animal origin 
 Neurotransmitters are released from neuronal terminals in response to an 
action potential and they interact with cell-surface receptors to elicit a biological 
response [3]. In the body, they transmit neuronal signals, respond to stress, regulate 
motor coordination and control homeostatic, gastrointestinal and psychomotor 
function [3, 4]. They also play a role in mood, anxiety, aggression, behavioural 
disorders which affect sleep, eating, sex and mood, neuropsychotic disorders and 
are molecular targets in Parkinson’s and Alzheimer’s disease [5, 6].  
 Neurotransmitters known to occur in vivo include the catecholamines 
dopamine, norepinephrine and epinephrine; and the indoleamine serotonin (Figure 
1.1) [3]. After signal transmission, the neurotransmitters are recycled or 
metabolised for excretion via urine: dopamine primarily to 3,4-
dihydroxyphenylacetic acid, homovanillic acid and norepinephrine; norepinephrine 
to 4-hydroxy-3-methoxyphenyl glycol, vanilmandelic acid and normetanephrine; 
epinephrine to 4-hydroxy-3-methoxyphenyl glycol and vanilmandelic acid; and 
serotonin to 5-hydroxyindole-3-acetic acid [3]. 
  
 
Figure 1.1: Structures of the neurotransmitters (a) nor-epinephrine, (b) dopamine 
and (c) serotonin. 
(b) 
(c) 
(a) 
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 Abnormal production, release and/or metabolism of neurotransmitters is 
implicated in anxiety, aggression, behavioural and psychotic disorders, as well as 
conditions such as Parkinson’s and Alzheimer’s disease and various cancers [3, 5-
10]. For example, catecholamine secreting tumours such as neuroblastoma elevate 
neurotransmitter levels in biological fluids and their metabolites in urine [4]. 
Metastases can occur a considerable time after diagnosis and treatment, therefore 
periodic screening of neurotransmitter levels in the body can assist diagnosis and 
monitoring [3, 4]. In more general terms, the determination of neurotransmitters is 
important to understand the biochemistry of brain function and the role of these 
compounds in a wide range of disorders [11-17].  
 
1.2.1 Neurotransmitters in the brain 
 Increased levels of dopamine, norepinephrine, and serotonin in a number of 
brain regions in have been linked to stress [18], decreased blood pressure and blood 
volume, thyroid hormone deficiency, congestive heart failure and heart arrhythmias 
[3]. Chronic tension headache, hypertension, schizophrenia, Duchenne’s muscular 
dystrophy and preeclampsia have all been associated with increased serotonin 
levels circulating the body, and low neurotransmitter levels have been noted in 
idiopathic postural hypotension [3]. Anticancer and psychoactive drug activity can 
also be monitored using catecholamine levels as they commonly act at 
neurotransmitter receptor sites [4, 10, 19, 20]. Given the wide range of roles 
neurotransmitters play in the body it is very difficult to treat abnormalities in their 
levels as diagnostic to any particular condition; rather they are used as part of a 
functional assessment of patient information [21]. In this thesis neurotransmitter 
Chapter One 
4 
 
levels are analysed in the rat brain (Figure 1.2) as it represents a relevant model to 
the human brain [22].  
 
   
Figure 1.2: Photographs of (a) a whole rat brain frozen at െ20 °C and (b) a thawed 
rat brain with the frontal lobe removed for further dissection and analysis in Chapter 
Four of this thesis. 
 
1.2.2 Neurotransmitter metabolites in urine 
 Urinary levels of their metabolites have been shown to closely reflect 
concentrations of the parent neurotransmitters within the central nervous system 
[23-25]. Although diet and lifestyle factors are known to influence urinary 
metabolites, they can be controlled in the lead up to sample collection making urine 
practical, non-invasive sample for establishing parent neurotransmitter levels in the 
diagnosis and monitoring of disease [26-31]. Appropriate control of diet and 
lifestyle factors minimises the expected inter sample variation and increases the 
confidence in comparisons of urine collected over multiple days during method 
development [30]. 
 
  Coffee: a chemically complex sample of plant origin 
 Coffee is an important source of natural antioxidants and is consumed 
worldwide for its physiological effects, aroma and taste [32-35]. These 
(a) (b) 
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antioxidants, such as flavonoids and other related phenolic compounds have 
important biological activities including the modulation of enzymes, activation of 
transcription factors and general gene expression [36]. Links have been made 
between the biological role of antioxidants and a lowered risk of degenerative 
diseases including chronic heart disease and cancer [37-39]. However, roasted 
coffee is a chemically complex sample [34], as it contains thousands of compounds 
with different chemical structures including plant phenolics, an abundance of 
proteins, amino acids, sugars and acidic molecules [32].  
 The chemical profile and complexity of coffee also varies due to natural 
influences such as the bean type, geographical origin and growing conditions; or 
from post-harvest influences such as the degree of roasting conducted [40, 41]. 
Consequently, reliable analytical methods for the separation and analysis of 
antioxidants in coffee will be of significance.  
 
  Preparation of complex samples for analysis 
 Sample preparation aims to concentrate and reduce the complexity of 
samples by selectively extracting analytes of interest prior to analysis [42]. 
Effective sample clean-up improves the chromatographic resolution and reduces 
analysis time, however elaborate procedures are unfavourable due time and 
complexity efficiency and degradation over large sample sets. Therefore the 
method development needs to compromise between clean samples and reducing 
time and cost during an analysis [43]. Sample preparation is often adapted to 
consider the analytical method, for example a derivatisation is included for 
fluorescence detection [15]. A detailed study into sample preparation is not a focus 
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of this thesis; therefore previously reported methods were adapted to use solvents 
compatible with those used in the analytical technique.  
 The nature of biological samples often requires that extra care be taken 
during sample preparation and handling. Materials containing neurotransmitters 
need to be prepared and stored with care to prevent oxidation of the catechol groups 
as they are light, temperature and pH sensitive [4]. In particular the brain tissue 
used was handled over equipment cooled by liquid nitrogen and stored at all times 
at െ80 °C. Samples were dissected in small amounts, homogenized in an aqueous 
acid, centrifuged and the supernatant for dilution, filtration and storage at െ80 °C 
prior to HPLC analysis [11, 15, 44-46]. Pre-treatment methods of urine samples 
vary more than brain tissue, with some methods only including sample dilution and 
filtration [47], with some adding acid for sample preservation [26, 27, 48, 49], and 
others including a solid phase extraction or hydrolysis to clean and concentrate 
samples [50]. Throughout this thesis acid was always added to preserve urine 
sample prior to dilution and filtration for HPLC analysis. 
 Hot water extraction of coffee was conducted using a machine to grind the 
beans and add the hot water, to replicate conditions used by those who consume 
coffee as a drink and for consistency with previously reported procedure [51-53]. 
Fresh samples were prepared daily and after filtration the extract was diluted to a 
suitable injection solvent concentration for analysis.  
  Sample dimensionality in complex samples 
 Dimensionality is defined as the number of individual variables that must 
be specified to identify each component in a sample and is useful to describe its 
complexity [54]. For instance, a mixture of straight chain alkenes has a sample 
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dimensionality of one- pertaining to the number of carbon atoms in the chain. 
Conversely, chemically complex samples such as brain, urine and coffee contain 
multiple classes of compounds and thus have high sample dimensionality. To 
resolve each of the dimensions an ideal analytical method requires the capacity to 
distinguish upon each independent variable, otherwise they all collapse into a 
single dimension. Naturally, due to the complexity and high dimensionality of 
these samples the ideal method is impossible to practically develop. Nonetheless, 
powerful analytical techniques are available and effective as they carefully utilise 
key sample characteristics to employ non-correlated detection and separation 
strategies within the method [54].  
 
2. Finding the components of chemically complex samples: 
chemiluminescence detection 
  General principles of chemiluminescence 
 Certain redox reactions yield light known as chemiluminescence, at 
wavelengths from the near-ultraviolet to the near-infrared [55]. 
Chemiluminescence occurs during the relaxation of an electronically excited 
product of a chemical reaction which is not accompanied by a dissipation of heat 
[55]  and is a well-established spectrometric branch of analytical chemistry [56, 
57]. Chemiluminescence emission requires sufficient energy from the reaction to 
form the excited state, a pathway to induce the energy for the transition and the 
efficient stimulation of molecules for releasing photons [57]. It is a useful analytical 
techniques as to a certain extent the emission intensity is relative the reaction rate 
[57] which is in turn dependent on concentration [56].  
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 A number of reagents have been described for applications involving liquid 
phase chemiluminescence, the most reported including luminol, lucigenin, 
tris(2,2’-bipyridyl)ruthenium(III), potassium permanganate, peroxyoxalates [55], 
cerium(IV), soluble manganese(IV) [56], acridinium esters, diaryloxalates, 
dioxetanes and hypohalites [55, 58]. Each of these reagents are suitable for 
particular classes of analytes in numerous applications including for the analysis of 
pharmaceuticals, controlled drugs [59-66] such as opioids (morphine [67] and 
heroin [68]), tranquilizers (loprazolam [69], nitrazepam [70]), stimulants 
(methamphetamine [71], cocaine [72]), hallucinogens (psilocin [73] and 
phencyclidine [74]) and cannabinoids [75].  
 Chemiluminescence is an attractive detection system for use with flow 
injection analysis and high performance liquid chromatography due to its simple 
reagent manifold design, high reproducibility, excellent compatibility with 
common solvents, rapid reactions [76] and sensitivity toward target analytes [62, 
77-80]. Chemiluminescence also provides an inherent level of selectivity as 
significant amounts of light can only obtained from a limited number of chemical 
reactions [55]. This selectivity can be advantageous for the freedom of 
measurement from interferences, or disadvantageous when attempting to find a 
universal detection method [55]. For the analysis of mixtures the reagents that yield 
emission with several species rely on a physical separation to remove interferences.  
  
  Acidic potassium permanganate as a chemiluminescence reagent 
 Acidic potassium permanganate chemiluminescence was first described by 
Harvey in 1917 [81] and initially used for analysis in 1975 for the determination of 
sulfur dioxide [82]. Whilst a number of other inorganic species have been 
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determined with acidic potassium permanganate post 1975, the pioneering work of 
Townshend’s group studying morphine in the mid 1980’s has led to organic 
analysis becoming the primary application of this reagent [67, 83-85]. To date a 
diverse range of organic compounds have been determined in pharmaceutical, 
clinical, forensic, food and agricultural settings using permanganate 
chemiluminescence [62, 86].  
 Analytically useful chemiluminescence from acidic potassium 
permanganate is typically generated from the oxidation of phenolic and amine 
compounds, particularly those with additional hydroxyl, alkoxyl or amino 
substituents [77-80]. The characteristic red emission of light from redox reactions 
with permanganate originates from an electronically excited Mn(II) species, which 
is thought to be generated via the reduction of an intermediate Mn(III) precursor by 
analyte radicals (originating from a reaction with Mn(VII)) (see Figure 1.3 and 
Scheme 1.1) [87-89].  
 
 
Figure 1.3: The characteristic red emission of light emanating from the reaction of 
acidic potassium permanganate with morphine in a coiled tubing flow cell. The 
reactants are merged just prior to entering the centre of the flow cell. 
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Scheme 1.2: Light producing pathway of permanganate chemiluminescence from 
the reduction of manganese(VII) to an excited manganese(II)- Mn(II)*- with a 
suitable analyte. 
 
  Enhancing the selectivity and sensitivity of permanganate 
chemiluminescence 
 Chemiluminescence reaction conditions are an important consideration 
during method development, as those that are required to produce the maximum 
emission intensity vary between different the classes of analytes capable of 
producing light [62, 75, 79, 80]. Important considerations for the redox reaction 
involving potassium permanganate are reagent concentration, pH, type and 
concentration of acid used, temperature, flow rate and mobile phase solvent [62].  
 The emission intensity from the acidic potassium permanganate reaction 
has been enhanced by adding compounds including polyphosphates and 
formaldehyde to the reagent, in addition to undertaking a partial preliminary 
reduction of Mn(VII) with Mn(II) or thiosulfate [62, 75, 76, 80, 89]. Whilst not 
Light 
Mn(VII) Analyte 
Mn(III) Analyte 
radicals 
Mn(II)* 
Mn(II) 
Other 
products 
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much is known about the mechanism of enhancement by formaldehyde, its 
presence can be very effective when merged with the reagent solution immediately 
prior to the analyte reaction [79]. Sodium polyphosphates, for instance, are 
dissolved in the reagent solution to stabilise the reaction intermediates and prevent 
the formation of insoluble Mn(IV) [62, 89, 90]. These, and other additives are used 
in the reagent solution to protect the excited state or generate an increased pool of 
the key emitting species, significantly increasing the light from those analytes that 
typically give a weak signal under ‘standard’ reagent conditions [89]. 
 During the application of acidic potassium permanganate 
chemiluminescence to the analysis of neurotransmitters and their metabolites in 
chemically complex samples, this thesis will compare a number of enhancers to 
develop methodology with optimal sensitivity. In particular the reagent conditions 
selected will be derived and optimised using previously developed methodology 
for the analysis of urine [47], cannabinoids [75] and other complex samples [62, 
86]. This thesis also seeks to further our understanding of the important properties 
of sodium polyphosphates for the enhancement of potassium permanganate 
chemiluminescence. Whilst a dual mechanism of enhancement has been postulated 
by Hindson and co-workers [89] the important properties of the polyphosphates 
were unknown. 
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3. Separating chemically complex samples: high performance 
liquid chromatography 
  One dimensional high performance liquid chromatography 
 High performance liquid chromatography (HPLC), popular for the 
separation and analysis of chemical mixtures, is a superior chromatographic 
method due to a number of advantages over other techniques [91]. It is remarkably 
precise, almost universally applicable and available in most laboratories thanks to 
the wide range of equipment and columns commercially produced [91]. The growth 
and development of HPLC expanded remarkably from the mid 1960’s before it 
plateaued in the 1990’s at a time when the primary requirements in terms of the 
separation process, equipment and columns had been satisfied [2, 91]. It was at this 
time that one dimensional techniques such as HPLC were viewed as capable of 
solving almost all analytical problems of practical interest [2].  
 However after the maturation of HPLC it became apparent that separation 
problems of critical importance involving chemically complex sample matrices 
could not be solved with one dimensional methods [2]. The separation methods 
available at the time simply could not provide the orders of magnitude in resolving 
power that was required [92]. From this need grew multidimensional 
chromatography, an approach that involves combining two or more different 
separation mechanisms that is considered to be a useful advance on single 
dimensional techniques [2]. 
 
  Two-dimensional high performance liquid chromatography 
(2D- HPLC) 
 To date 2D-HPLC has become a significant research field in the separation 
sciences to separate complex sample matrices as it is capable of providing superior 
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peak capacity compared to single dimension methods [2]. Careful method 
development is vital to ensure that 2D-HPLC is capable of far outperforming one-
dimensional separations [2, 93]. Whilst separation power theoretically increases 
with the number of dimensions two are the practical limit in terms of instrumental 
configuration and analysis time [2]. Even so, complex samples including 
pharmaceuticals with co-eluting enantiomers [94], polymers [95], peptides and 
proteomic samples [96], metabolic samples, oils, fats [97] and synthetic polymers 
[95] have been analysed using 2D-HPLC.  
Depending on the desired outcome a 2D-HPLC method is either carried out 
in the comprehensive mode where all fractions are collected from the first 
dimension for analysis on the second, or using the heart cutting approach where 
only subsets thereof are subjected to both separations [98]. Consequently analysis 
times can be comparable to one-dimensional methods (heart cutting) or 
significantly longer (comprehensive), forcing a trade off with the gain in resolution 
and peak capacity [2, 98, 99]. Furthermore, subject to the available instrumentation 
2D-HPLC can be performed in off-line mode where fractions are collected from 
the first dimension and stored before being exchanged to the second; or in the online 
mode where the separations are interfaced via a switching valve, and each analysis 
in the second dimension is completed in time for the next transfer of eluent from 
the first [2].  
 
 Assessing the performance of 2D-HPLC: theory 
An orthogonal 2D-HPLC method employs independent separation 
mechanisms in each dimension to achieve the greatest selectivity difference 
between them [2]. In practice an orthogonal separation rarely exists, however it is 
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still a useful measure to calculate for the assessment of a 2D-HPLC method. A 
number of statistical measures of orthogonality exist including spreading angle (ߚ) 
where a value of 90o represents a truly orthogonal system; and correlation, where a 
measure of one indicates a fully related separation whilst zero signifies true 
independence [100]. 
Peak capacity (the number of peaks that can be separated in a single run) of 
a 2D-HPLC separation can be as high as the product of the values of the constituent 
dimensions if the system is orthogonal [100, 101]. The practical peak capacity of a 
2D separation is usually considerably lower than the theoretical value due to the 
overlap of component zones [102, 103]. The conditional peak capacity is often 
considered in practical applications and calculated for each individual dimension 
via Equation 1.1 [104, 105]: 
 ݊௖ ൌ  ௧ೃሺீ௡ሻି௧ೃሺீଵሻௐ  Equation 1.1 
where ݊௖ represents peak capacity, ݐோሺܩ݊ሻ and ݐோሺܩͳሻ are the retention times of 
the last and first components of interest in the analysis and W represents the average 
width of the peaks in the separation. By calculating the conditional peak capacity 
of each individual dimension via Equation 1.1 the overall peak capacity, ݊௖ǡଶ஽, can 
be determined using Equation 1.2 [106]:  
  ݊௖ǡଶ஽ ൌ  ௡೎ǡభൈ௡೎ǡమൈ௙೎೚ೡ೐ೝೌ೒೐ۃఉۄ  Equation 1.2 
where ݊௖ǡଵ and ݊௖ǡଶ are calculated using Equation 1.1 for the first and second 
dimensions, respectively, ௖݂௢௩௘௥௔௚௘ represents the amount of surface space that is 
utilised by the separation and ۃߚۄ is the first dimension broadening factor that is 
related to the effect of the sampling rate has on the overall peak capacity. The term 
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௖݂௢௩௘௥௔௚௘ is used interchangeably with orthogonality, (ܱ) [107], and can be 
calculated from Equation 1.4, whilst ۃߚۄ is calculated using Equation 1.3 [108]: 
 ۃߚۄ ൌ ටͳ ൅ ͲǤʹͳͶሺ௧ೞఙభሻଶ Equation 1.3 
where ݐ௦ is the sampling time and ߪଵ is the average standard deviation of peaks 
eluted in the first dimension. A greater number of fractions transferred to the second 
dimension will result in higher 2D-HPLC resolution, however, to provide the 
optimal analysis time whilst maintaining resolution the Murphy-Schure-Foley rule 
recommends the transfer of 3 to 4 fractions per 8ߪ peak [109]. Similarly, the 
approach to develop 2D-HPLC parameters by Vivó-Truyols [110] recommends 
between 2 and 3 cuts and the theoretical optimisation by Horie et al. [111] suggests 
a modulation period of between 2.2 and 4 times the standard deviation of a peak. 
 
3.3.1. Calculating spreading angle via a geometric approach to factor 
analysis (GAFA) 
To compare the analytical performance of different systems a procedure is 
required to relate orthogonality (independence) and peak capacity between 
separations. One such procedure developed by Liu, Patterson and Lee [102] 
involves computing correlation and peak spreading angle matrices using retention 
data, estimating theoretical peak capacity from the separate dimension values and 
finally taking into account the degree of orthogonality.  
This approach uses the two sets of independent retention data that are 
simultaneously generated in 2D chromatographic separations, where each are 
assumed to be independent vectors that represent interactions between solutes and 
the stationary phase under the given conditions. Correlations of the two retention 
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vectors can be calculated in a similar way to other applications of factor analysis 
that aim to represent data vectors in space with lower dimensionality while 
preserving information content and to allow a better understanding of the 
phenomenon under consideration. A geometric approach to factor analysis (GAFA) 
can calculate correlations between a pair of retention vectors to give a measure of 
the interaction between the vectors, inform choices regarding column selection and 
to perform optimisation of column combinations for specific separation problems.  
The equations used for GAFA derived by Liu, Patterson and Lee [102] give 
an accurate calculation of resolving power and have been utilised in many two 
dimensional applications, including calculating correlation coefficient and practical 
peak capacity in the analysis of phenolic [112], terpene [113] and herb [114] sample 
matrices. A GAFA calculates the spreading angle between dimensions by 
visualising the peak capacity in rectangular plots. The effective separation space 
used is illustrated by plotting the respective peak capacity from each dimension on 
the axes. The utilised separation space is given by the region bound between the 
spreading angles. The separation is orthogonal when the spreading angle is equal 
to 90° and becomes more correlated as the measure is smaller. A more detailed 
explanation of the geometric approach to factor analysis is given by Liu and co-
workers [102]. 
 
3.3.2. Calculating fractional surface coverage using the bins method 
Orthogonality (ܱ) was calculated using the bins method, as this was 
considered useful by Gilar and co-workers [115] after undertaking a review of the 
current popular techniques. This method is robust for measuring surface coverage 
of separations with varying numbers of components. Separation space is divided 
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into a given number of bins (Pmax) equal to the number of peaks [115], then Ʃbins 
was calculated by counting all normalised bins containing peaks [107]. An 
orthogonality value of between 0 and 1 is then yielded using Equation 1.4 [107]: 
 ܱ ൌ ᎂ௕௜௡௦ିඥ௉೘ೌೣ଴Ǥ଺ଷ௉೘ೌೣ   Equation 1.4 
The orthogonality value is then expressed as a percentage for comparison.  
 
 Overcoming solvent mismatch in 2D-HPLC  
 Maximising peak capacity is a significant goal during the development of 
2D-HPLC methodology in order to solve separation problems that involve 
chemically complex samples [2]. These separations are important in areas such as 
environmental analysis, metabolomics, molecular biology and food analysis [2]. 
High peak capacities have been achieved by coupling unique retention mechanisms 
to ensure the entire separation space is used; however, the most divergent of HPLC 
phases (such as reversed and normal) are naturally incompatible due to the physical 
effects of solvent immiscibility [2, 103, 107]. Strategies to couple mismatched 
HPLC eluent compositions have been developed, but they have inherent limitations 
such as a requirement for specialist equipment and solvents, long treatment times 
and compromised resolution or sensitivity [116-118].  
 Coupling two dimensions of the same mode, i.e. reversed phase (RP) × RP, 
is a routine solution for circumventing the problems caused by solvent 
immiscibility in 2D-HPLC [119-121]. However, problems such as solvent 
breakthrough [122], solvation and viscosity differences are often overlooked [119-
123]. The deleterious effects of mismatch when strong solvent plugs are injected 
into weaker mobile phases, as in the case of gradient RP × RP, have been reported 
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by several research groups [52, 124, 125]. In these instances the solvent mismatch 
typically leads to zone broadening where the profile ceases to be Gaussian and peak 
splitting occurs, caused by the slow transfer of solute from mobile to stationary 
phase [52, 124-126]. 
To overcome the difficulties experienced with solvent mismatch, the first 
dimension can be run in isocratic mode, which allows for transfer of a consistent 
injection plug concentration and the use of a full gradient in the second. 
Unfortunately, this leads to longer elution times and lost separation space [126, 
127]. In order to retain the benefits of a gradient separation, Layne and co-workers 
[122] suggested diluting the first dimension eluent fractions with a weak solvent 
and extending the gradient time, or using a column with larger inner diameter. Both 
of these approaches, however, are unsuitable for use with the fast second dimension 
gradients required for online 2D-HPLC. A shift gradient has also been reported 
whereby a relatively shallow change in the gradient terminals is implemented in the 
second dimension, so that the plug being transferred between the two columns is 
closer to the initial gradient concentration [128, 129]. This protocol combines all 
the benefits of full and parallel gradients with shorter re-equilibration time, but does 
so at the expense of overall peak capacity [129].  
Stevenson and co-workers [52] have described an alternative stratagem 
coupling HILIC and RP-HPLC for the separation of a coffee extract, which 
employed a counter gradient that was merged with eluent fractions as they were 
collected to artificially control the second dimension injection solvent [52, 53]. This 
counter gradient gave a 2D-HPLC separation of coffee that occupied 71% of the 
space from a previously indecipherable retention profile [52], and was also 
successfully used in a RP × RP 2D-HPLC analysis of human urine [53]. However, 
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to operate the counter gradient, an additional HPLC pump was required. Moreover, 
fractions from the first dimension were diluted (reducing sensitivity) and the 
method was restricted to a minimum of approximately 20% solvent composition 
before several experimental design issues arose [52]. A comparison of new 
approaches to overcoming solvent mismatch in 2D-HPLC is explored in Chapter 
Five of this thesis. 
 
  In-silico chromatography modelling using DryLab® 
 Optimising the experimental parameters for HPLC can be assisted by using 
simulation software which can predict chromatography on any reversed phase 
system based on the elution data from only two trial separations per parameter 
[130]. It is capable of instantaneous modelling [131], realising large savings in the 
required instrument time and solvent use. DryLab®, developed by Molnár Institute 
models chromatograms by extrapolating the key retention parameters for each peak 
[130, 132-135], with the simulated results found to be in very close agreement with 
the real results [133].  
 DryLab® comprises a number of tools to assist with chromatographic 
modelling from real data. These included colour coded maps which plot critical 
resolution as a function of one or two key method parameters, predicted 
chromatograms, peak tracking based on peak area and molecular mass and a 
gradient editor that allows the use of step gradients [136]. The software is also 
capable of modelling the parameters including gradient time, temperature, pH, 
eluent composition, isocratic conditions, ionic strength, additive and buffer 
concentrations [136]. DryLab® has been widely been used to assist in HPLC 
optimisation, with over 110 references found since its development in 1986 using 
Chapter One 
20 
 
SciFinder® (search: Drylab, refined to chromatography, duplicates removed, 
searched March 17 2015). In addition to DryLab® there are many other 
chromatography modelling software packages available [130, 137], however as 
they were not used in this thesis they will not be discussed. 
 DryLab® is capable of predicting chromatography on any reversed phase 
HPLC system based on only two training separations per parameter, such as two 
gradient times or two column temperatures [130]. This allows DryLab® to 
calculate values for the average retention factor ( ത݇) and the molecular footprint of 
the solute as it traverses the pathway of the chromatographic retention media (S) 
[138] for each solute via a set of simultaneous equations [132, 139], assuming pre-
elution and post-elution of solutes can be ignored: 
 ݐ௚ǡଵ ൌ ሺݐ଴Ȁܾଵሻ ሺʹǤ͵݇଴ܾଵ ൅ ͳሻ ൅ ݐ଴ ൅ ݐ஽  Equation 1.5 
and 
 ݐ௚ǡଶ ൌ ሺݐ଴Ȁܾଶሻ ሺʹǤ͵݇଴ܾଶ ൅ ͳሻ ൅ ݐ଴ ൅ ݐ஽  Equation 1.6 
where tg,1 and tg,2 are the retention times for the two training gradient times, t0 is the 
time required to elute and un-retained marker and tD is the dwell time of the system, 
i.e. the time required for concentration changes in the mobile phase to leave the 
pump and enter the column head. The parameters b1 and b2 represent gradients of 
different steepness given as [132]: 
 ܾ ൌ ଴ܸοߔܵȀݐீܨ Equation 1.7 
where V0 is the column dead volume, usually measured with an un-retained marker, 
ΔΦ is the change of the strong mobile phase component, Φ, during the gradient, tG 
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is the gradient time and F is the mobile phase flow rate. The parameter k0 refers to 
the original retention factor, k’, at the beginning of the gradient according to [132]: 
  ݇ᇱ ൌ  ݇௪ െ ܵߔ଴ Equation 1.8 
where kw is the extrapolated retention factor in the weak mobile phase constituent, 
usually water and ߔ଴ is the initial value of strong solvent in the gradient. Subtle 
gradient changes which can modify the elution order and resolution of a HPLC 
separation can be simulated relatively easily using the above Equations 1.3 to 1.6. 
Using the resolution maps in DryLab® the mobile phase conditions that will 
provide greatest peak capacity can easily be found. Dolan and co-workers [132] 
have compared a number of real separations with those simulated in silico by the 
software, and found very close agreement. Importantly the modelling can be 
completed instantaneously on modern computers, substantially reducing the 
required instrument time and solvent use [131].  
 
4. Project Aims 
 Robust analytical methodologies are vital for solving important separation 
problems for chemically complex sample matrices, so much so that advances in the 
procedures are often directly linked to key discoveries in biotechnology and the life 
sciences. The work presented in this thesis aims to explore key aspects of 2D-HPLC 
separations and detection, to improve its applicability for routine application in the 
analysis of chemically complex samples. 
 The challenges of method development and different strategies are 
compared and addressed using the chromatography simulator DryLab®. The use 
of temperature programmed separations are investigated for the analysis of coffee 
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and human urine samples, in order to overcome problems associated with solvent 
mismatch between separation dimensions. This thesis also pays attention to acidic 
potassium permanganate chemiluminescence as a sensitive method of detection 
with some selectivity towards compounds able to participate in a redox reaction 
with the reagent. Both separation and detection are considered for the development 
of a two-dimensional method for the determination of neurotransmitters and their 
metabolites in human urine.  
 Finally, a comprehensive analysis of the important characteristics of sodium 
polyphosphates in the enhancement of acidic potassium permanganate 
chemiluminescence was conducted. The aim of this comparison was to reveal key 
properties of polyphosphates important for their activity in the dual enhancement 
mechanism of permanganate chemiluminescence for improved detection 
sensitivity. 
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Overview of instrumentation 
1. Chromatographic techniques 
  High performance liquid chromatography 
 Liquid chromatography, first developed in the early 1900’s, is a method 
used for the physical separation of mixtures by distributing their components 
between a moving liquid phase and a stationary phase [91]. Reversed phase liquid 
chromatography uses a non-polar adsorbent stationary phase with a more polar 
mobile phase and is the most widely employed form of liquid chromatography, as 
it is suitable for the separation of a large number of compounds which show 
variation in polarity and structure [91, 140]. There are a wide range of stationary 
phases available, which are commonly based on the chemical modification of silica 
support materials, used in conjunction with mobile phases consisting a mixture of 
water and an organic modifier such as methanol or acetonitrile [91].  
 High performance liquid chromatography (HPLC) is a widely used 
development of liquid chromatography, with modern day instruments evolving 
from those described by Csaba Horváth in the USA and Josef Huber in Europe 
[141]. The popularity of HPLC for the separation and analysis of chemical mixtures 
is driven by its almost universal applicability, remarkable precision, extensive 
range of equipment commercially available and the abundance of instruments in 
laboratories worldwide [91]. A small volume of sample is injected onto a column 
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and separation occurs by the differing analyte affinity to the column stationary 
phase when a mobile phase is passed through [142].  
Two-dimensional HPLC (2D-HPLC) is increasingly popular due to the 
significant gains in resolution available from a simple reconfiguration of modern 
instrumentation (for further information see Chapter One) [2]. The switching valve 
configuration used for online 2D-HPLC in this thesis is shown below in Figure 2.1, 
where the respective valve positions are shown in dashed and solid red lines. 
 
 
Figure 2.1: Schematic of the switching valve set up used for online 2D-HPLC 
during this thesis. The dashed line valve position shows the filling of the lower loop 
from the first dimension whilst the upper loop is emptying into the second 
dimension. The solid red line valve position shows filling of the upper loop while 
the lower is emptying into the second dimension. 
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  Ion chromatography 
 Any modern and efficient method for the separation and determination of 
ions based on ion exchange resins is known as ion chromatography [143, 144]. 
Since its development in the mid 1970’s ion chromatography has become the 
preferred method for the determination of inorganic anions and small organic 
anions, whilst techniques including inductively coupled plasma mass spectrometry 
are more widely used for cation analysis [143, 145]. Applications of ion 
chromatography are numerous [146-148] and include the analysis of drinking water 
[149], food stuffs [150], biological liquids [151], saline solutions [152], 
semiconductors [153] and environmental samples [154-157]. As the equipment is 
relatively inexpensive, ion chromatography itself is cost effective and efficient for 
the determination of many ions in a single run [145]. Separation is commonly 
performed on columns with ion exchange resins, where the analyte ions are 
continuously exchanged with counter ions within the resin [143]. One counter ion 
is exchanged for each ion charge, so that electrical neutrality is maintained. Ions of 
the opposite charge are repelled by the resin. The mobile phase is a solution 
containing anions and cations and replaces almost all of the exchange ions in the 
column [144]. Once the sample is injected the constant flow of the pump moves the 
band along the column and the ions compete with the eluent [143]. 
 In this thesis two forms of detection are used with ion chromatography- 
inductively coupled plasma mass spectrometry which is detailed later in this 
chapter, and an anion suppressor and electrochemical conductivity detection, on 
which a short discussion follows. The anion suppressor is a column immediately 
following the ion exchange column, packed with an ion-exchange resin that 
converts ions from the eluent solvent into molecular species with limited ionisation, 
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so they do not affect the conductivity of the analyte ions [158]. The suppressor 
packing is the acid form of a cation-exchange resin and does not retain the analyte 
of interest [142]. The suppressor column allows use of conductivity detectors, 
which have many ideal properties including universality, sensitivity, predictable 
responses to concentration changes, are inexpensive and reliable [142]. The 
analysis of polyphosphate mixtures using a suppressor with conductivity detection 
has been described previously by a number of reports [159-164]. 
 
2. Chemiluminescence instrumentation 
  Flow injection analysis 
 Ruzicka and Hansen in Denmark [165] and Stewart et al. [166] in the USA  
introduced flow injection analysis (FIA) in 1975 as a laboratory method for rapid 
sample handling. Reactions in FIA occur via dispersion, where precise aliquots of 
sample are injected into a continuously flowing carrier stream, prior to merging 
with a reagent [144]. Flow injection analysis is well suited to rapid 
chemiluminescence reaction as two solutions can be reproducibly merged close to 
the detector in a system that is carefully optimised to ensure the maximum amount 
of light is captured by the photomultiplier tube [55, 58, 167-170].  
 Flow injection analysis has received widespread utility in the quantification 
of analytes in sample matrices; exploration of the fundamental chemistry behind 
chemiluminescence reactions and in the optimisation of post-column reactions for 
liquid chromatography applications [62, 170]. However, the simplicity of FIA and 
lack of a separation in traditional manifolds means that it does not have the 
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selectivity to determine multiple analytes within chemically complex samples [55, 
58, 169].  
 
  Sequential injection analysis 
 Sequential injection analysis (SIA) was developed by Ruzicka and Marshall 
in 1989 [171] as an automated method to address shortcomings of FIA including 
its applicability in the industrial environment. Sequential injection is much more 
complex than traditional flow injection systems for process analysis. It uses 
minimal volumes of reagents per cycle, produces far less waste and the same 
manifold configuration is appropriate for a wide range of chemistries [171]. It has 
the ability to stack the sample and reagents in any order, in precisely defined zones 
that are mixed to form products [172]. Combined with the use of piston pumps SIA 
is more robust and simpler as a system for automated liquid handling. A 
disadvantage is lower sample throughput as the stacking of reagents and sample in 
a holding coil gives longer run times than FIA [173].  
 The operation of SIA is similar to FIA in that a sample is aspirated into the 
instrument, the chemistry performed and detected before being expelled to waste 
[172]. Reproducible sample handling is achieved using computer controlled 
instrumentation consisting of a valve, pump and detector operating synchronously 
[172]. Aliquots of carrier solution, sample and reagent are aspirated sequentially 
into a holding coil by operating the pump in reverse. The flow of the pump is then 
reversed and a zone of detectable product is formed after propulsion of the reagents 
into a flow cell for mixing. Sequential injection has been employed for the analysis 
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of a wide variety of analytes in samples including foods, beverages, environmental, 
pharmaceutical and industrial processes [172].  
 This automation of SIA makes it suited to the analysis of reagent stability 
over time in the presence of different polyphosphate samples in this thesis. 
 
3. Phosphorus-31 nuclear magnetic resonance spectroscopy 
 Nuclear magnetic resonance (NMR) is the utilisation of the absorption by 
nuclei in the radio-frequency region of electromagnetic radiation and is one of the 
most powerful tools available for the structural elucidation of organic and inorganic 
species [144]. The typical Fourier transform NMR spectrometer consists centrally 
of a highly stable magnet where the sample is placed, surrounded by a 
transmitter/receiver coil [144]. A continuous oscillator produces excitation pulses, 
which pass to a switch that creates an intense and reproducible pulse of radiation 
that passes into the transmitter coil [144]. The same coil then picks up the signal 
and amplifies it before transmittance to a detector. The signal is then digitized and 
collected for frequency analysis.  
 Phosphorus-31 exhibits sharp NMR signals with chemical shifts that extend 
over a range of 700 ppm [144]. Resonance from phosphorus-31 has been utilised 
in the biochemical field for applications such as investigating the energy source 
adenosine triphosphate in the body, and will be applied to the structural elucidation 
and characterisation of a range of polyphosphate mixtures [144, 162]. 
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The importance of chain length for the polyphosphate 
enhancement of acidic potassium permanganate 
chemiluminescence: improving complex sample detection 
 
1. Introduction 
Several different compounds have been found to enhance the emission 
intensity from acidic potassium permanganate chemiluminescence, including low 
molecular weight aldehydes, sodium thiosulfate and polyphosphates [62, 86]. 
Polyphosphates (chains of four or more repeating phosphate units) are a popular 
choice of enhancer as they are innocuous, stable, and have given up to 50-fold 
increases in permanganate chemiluminescence intensity [62, 86]. In 1986 Abbott 
and co-workers [67] first reported a very rapid initial production of light from the 
presence of phosphate species when using permanganate chemiluminescence for 
the determination of morphine. Their study compared orthophosphate, 
orthophosphoric acid, pyrophosphate, triphosphate and polyphosphoric acid, with 
the largest increase in emission intensity observed in the presence of the latter [67]. 
It was proposed that after the permanganate was reduced by morphine, a 
manganese-polyphosphoric acid complex was formed [67], which became stronger 
as the polyphosphate chain length increased [174]. However, the use of 
polyphosphoric acids is associated with noisy and irreproducible 
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chemiluminescence responses, and the stability of these acids in water is low [175, 
176]. 
In 2002 Barnett and co-workers [87] reported a 50-fold enhancement of 
permanganate chemiluminescence from hexametaphosphate after examining 
numerous different complexing agents. Although the mechanism of enhancement 
is yet to be completely elucidated, they observed a shift in the maximum emission 
wavelength from approximately 734 nm to 689 nm in the presence of 
polyphosphates, indicating that a strong interaction is occurring with the emitter 
[62, 87, 89]. In 2010 Hindson and co-workers [89] postulated a dual mechanism of 
permanganate chemiluminescence enhancement involving polyphosphates and 
their formation of strong complexes with Mn(III). This mechanism involved 
stabilisation of the Mn(III) precursor by polyphosphates to prevent 
disproportionation to Mn(IV) oxides that would otherwise flocculate under the 
mildly acidic conditions [177-179]; and the formation of protective “cage-like” 
structures around the excited Mn(II) emitter that inhibited non-radiative relaxation 
(Scheme 3.1) [89]. Hindson and co-workers [89] also concluded that the shorter 
chain ortho- and pyro-phosphate species prevent disproportionation of Mn(III) by 
the formation of complexes [174], but do not form protecting structures around the 
emitter due to the absence of a blue shift in the emission spectrum [89].  
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λmax 689 nm  
 
 
      
Scheme 3.1: Postulated light producing pathway of permanganate 
chemiluminescence in the presence of polyphosphates (PP) [89]. “A” refers to 
analyte. 
 
Sodium hexametaphosphate, or Graham’s salt, the common commercially 
available form of polyphosphate [180] is in fact a complex mixture of mostly linear 
oligomers with a wide range of chain lengths [181]. Polyphosphate products can be 
characterised by their average number of phosphate atoms per oligomer, or average 
chain length (n), which typically ranges from 4.5 to 18 [180]. While manganese-
polyphosphate complexes are more stable as the chain length increases, the end 
groups of the longer oligomers have a lesser influence on strength, because their 
contribution to the overall charge is lower [174]. Also, the linear polyphosphates 
generally exhibit stronger complexing power relative to their cyclic counterparts 
due to the greater net charge at each end of the chain compared to the middle groups 
[180]. 
Chemiluminescence reactions with permanganate have been enhanced with 
polyphosphates from a variety of sources [62], but the influence of the average 
chain length (n > 4) on emission intensity is not understood. It is also unknown why 
the greatest enhancement requires that the polyphosphates be present in large 
-e- 
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Aoxidised 
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excess (e.g. 1% m/v) compared to permanganate (1.0 mM; 0.0158% m/v) [62, 78]. 
It has been postulated that a large excess favours the formation of the protective 
cage-like structures and the maintenance of their structural integrity throughout the 
reaction [89]. Given that polyphosphates are a complex mixture of oligomers [181], 
it is also possible that such large excesses are required to ensure sufficient quantities 
of those that play a role in the enhancement mechanism. 
This chapter examines and compares a series of commercially available 
polyphosphate materials for their oligomer distribution and efficacy as enhancers 
of acidic potassium permanganate chemiluminescence. Polyphosphate 
concentration will also be examined for its influence on both the dual mechanism 
of enhancement and stability of reagent solutions under analytically useful 
conditions. 
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2. Experimental  
  Chemicals and reagents 
 Potassium permanganate (AR Grade) and methanol (AR Grade) were 
obtained from Chem Supply (Gilman, SA, Australia). Sulfuric acid (98%) and 
manganese plasma emission standard (for ICP, EM Science) were supplied by 
Merck (Kilsyth, Victoria, Australia). Deuterium oxide was supplied by Cambridge 
Isotope Laboratories (Tewksbury, MA, USA). Sodium thiosulfate (t98%), 
potassium hydroxide, concentrated ammonium hydroxide (Fluka) and bisphenol A 
were purchased from Sigma-Aldrich (Castle Hill, NSW, Australia). Nitric acid 
(70%) was supplied by Univar (Ingleburn, NSW, Australia). Ammonium chloride 
was sourced from BDH Chemicals (Frenchs Forest, NSW, Australia). Morphine 
was sourced from GlaxoSmithKline (Port Fairy, Victoria, Australia). Stock 
solutions of morphine (1 × 10-3 M) were prepared in acidified deionised water and 
sonicated to aid dissolution. Bisphenol A (1 × 10-3 M) was prepared in methanol 
and diluted in deionised water as required. 
 The 16 phosphate samples obtained for comparison were sodium 
dihydrogen orthophosphate, NaH2PO4, from Univar (Ingleburn, NSW, Australia); 
tetrasodium pyrophosphate, Na4P2O7, from AnalaR (VWR International, Murrarie, 
Queensland, Australia); sodium hexametaphosphate, (NaPO3)6, polyphosphate 
sodium salt, (NaPO3)n, (+200 mesh), sodium polyphosphate crystals (+80 mesh), 
trisodium trimetaphosphate, Na3P3O9, tri-polyphosphate, Na5P3O10, sodium 
hexametaphosphate (65-70% P2O5 basis), and sodium phosphate glass from 
Sigma-Aldrich; sodium hexametaphosphate P60 and P68 from Fibrisol 
(Heatherton, Victoria, Australia); Budit 3H, 4H, 6H, 7H and 8H instantised sodium 
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polyphosphate, Budit 7N coarse powder sodium polyphosphate, and FFB 779 
(Budit 9N replacement) sodium polyphosphate powder from BassTech 
International (Fort Lea, NJ, USA). 
 The reagents for flow injection analysis (FIA) were prepared by dissolving 
the potassium permanganate in water (1 × 10-3 M), adding the sodium 
polyphosphate and adjusting to pH 2.5 using sulfuric acid. The ‘enhanced’ 
permanganate reagents [76] for UV-visible absorption analysis were prepared in 
the same manner, except that the initial potassium permanganate concentration was 
1.9 × 10-3 M. Sodium thiosulfate was added as required to a final concentration 
of 1 × 10- 3 M, using an appropriate volume of a 0.1 M stock solution. 
 
 31P NMR 
 Solution 31P NMR was performed by dissolution of polyphosphates 
(approximately 70 mg) in 0.6 mL deionised water and 0.1 mL deuterium oxide (for 
signal lock). Phosphorous NMR measurements were recorded on a Bruker 
AVANCE 500 spectrometer (Bruker, Karlsruhe, Germany) operating at 202 MHz, 
with an acquisition time of 1.63 s. Temperature was regulated at 25 qC and 64 
scans were collected. Chemical shifts were referenced to H3PO4 in acetone. 
Equation 3.1 was used to calculate the average chain length (n) of each 
polyphosphate sample after detailed integration [162], where PP1 refers to total 
integration of the terminal (end group) phosphates, PP2 and PP3 to second and 
third position phosphates, and PPn to the inner phosphates.  
 
 ݊ ൌ  ሺ௉௉ଵା௉௉ଶା ௉௉ଷା௉௉௡ሻൈଶ௉௉ଵ  Equation 3.1 
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 PP1 was determined by total integration of signals resonating between -5 
and -8 ppm, while PP2, PP3 and PPn were determined by integrals in the spectral 
zone between -19 and -23 ppm. 
 
  Modified end group titration 
 A modified end-group titration without hydrolysis [182] was performed 
using an automated potentiometric titrator, a Metrohm 907 Titrando (Metrohm, 
FL, USA) controlled by Tiamo 2.3 software. Dilute hydrochloric acid solution 
(2 M) was prepared from analytical grade concentrated hydrochloric acid 
(32% w/w, Chem Supply, Gilman, SA, Australia). Sodium hydroxide (0.1 M) was 
prepared from sodium hydroxide pellets (Ajax Finechem, Taren Point, NSW, 
Australia) and standardised against analytical reagent grade potassium hydrogen 
phthalate (Fisher Scientific, Loughborough, Leicester, UK). Polyphosphate 
samples were prepared by complete dissolution in deionised water (2% m/v).  
 The average chain length was calculated using the variables obtained 
from a multi-step titration via Equations 3.2, 3.3 and 3.4 as detailed by Griffith 
[182]. The procedure involved titrating from the original pH of the polyphosphate 
solution (in water) to the first end point at approximately pH 9 with sodium 
hydroxide, to measure the hydrogen associated with phosphorus (part 1). The pH 
was then lowered to approximately 3 using hydrochloric acid and titrated to a 
second end point at approximately pH 4.5 with sodium hydroxide (part 2). The 
final part of the titration measured the volume of base required to titrate to a third 
end point at pH 9 (part 3). Part 3 of the titration was a measure of the weak acid 
function from the end group phosphates and orthophosphates. 
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 Equation 3.2 is used to calculate Y, the molar equivalent weight of middle 
groups in the mixture:  
 ܻ ൌ ௐାሺேǤ௠௅ಲሻሺ଴Ǥ଴ଶଶ଴ሻିሺேǤ௠௅ಳሻሺ଴Ǥଵଷଷ଴ሻ଴Ǥଵ଴ଶ଴  Equation 3.2 
 
where W is the weight of polyphosphate in grams, N is the normality of the sodium 
hydroxide used and mLA and mLB is the volume of base used in parts 1 and 3 
respectively.  
 The molar equivalent weight of end groups in the mixture, X, is given by: 
 ܺ ൌ ܰǤ݉ܮ஻   Equation 3.3 
 Equation 3.4 is then used to calculate average chain length (n) using the 
variables X and Y: 
 ݊ ൌ  ଶ௒௑  Equation 3.4 
 
  Flow injection analysis (FIA) 
 The analytes were injected (70 μL) on a simple two-line FIA manifold with 
an automated six-port valve (Valco Instruments, Houston, TX, USA) into a 
deionised water carrier stream. These were merged at a T-piece with the acidic 
potassium permanganate reagent prior to entering a coiled-tubing detection flow-
cell comprising 0.8 mm i.d. PTFE tubing (DKSH, Caboolture, Queensland, 
Australia). The carrier and reagent lines were propelled through 0.8 mm i.d. PTFE 
tubing (DKSH) at 4 mL min-1 using a peristaltic pump (Gilson Minipuls 3, John 
Morris Scientific, Balwyn, Victoria, Australia) with bridged PVC tubing (DKSH). 
The flow-cell was mounted flush against the window of a photomultiplier tube 
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(Electron Tubes model 9828SB; ETP, NSW, Australia) encased in a light tight 
housing and powered by a stable power supply at 950 V. Chemiluminescence 
intensities were documented with a chart recorder (YEW type3066, Yokogawa 
Hokushin Electric, Tokyo, Japan) and as FIA benefits from fast reaction times and 
very good reproducibility peak heights were used for quantification [183].  
 
  Ion chromatography 
 Ion separations were carried out using an ICS 3000 chromatography system 
(Dionex, Thermo Scientific, Sunnyvale, CA, USA). The system was equipped with 
an autosampler, eluent generation system, anion suppressor and electrochemical 
conductivity detector. Chromeleon software (version 7.1, Dionex) was used for 
data acquisition and instrument control. Separation was carried out using a 250 × 
4.0 mm ID column IonPac AS-19 (Dionex), with a 200 μL injection volume and 1 
mL min-1 flow rate. A 60 min potassium hydroxide gradient was used, starting at 
40 mM and increasing linearly to 100 mM over the first 10 min, then held at 
100 mM for the remaining 50 min. The column was re-equilibrated for fifteen 
minutes prior to subsequent analyses. Samples were prepared at 1000 ppm and 
standards at 200 ppm in a 40 mM potassium hydroxide solution, and analysed in 
duplicate.  
 
  Ion chromatography × inductively coupled plasma-mass 
spectrometry  
 For inductively coupled plasma-mass spectrometry measurements the 
separation was carried out using a Dionex DX-120 ion chromatograph (Dionex, 
Thermo Scientific, Sunnyvale, CA, USA). Polyphosphates were prepared at 
100 ppm in water and analysed in duplicate. Manganese(II) was added at 1 ppm 
Chapter Three 
38 
 
where specified. Separation was carried out using a Dionex Ion pack AS9-Hc anion 
exchange column (PEEK, 250 × 4.0 mm × 9 μm), with a 50 × 4 mm Guard Column 
fitted (Dionex), with injection carried out using the instrument injection port. 
Separation was performed in the isocratic elution mode using a mobile phase 
containing 180 mM ammonium chloride, adjusted to pH 9.3 using ammonia, with 
a flow rate of 0.8 mL min-1. The outlet of the chromatographic column was 
connected to an Agilent 7500c octupole reaction system inductively coupled 
plasma mass spectrometer (Agilent Technologies). For data acquisition, the time 
resolved analysis mode was used with 1 s integration time per mass.  
 
  Spectrophotometric monitoring 
 A Cary 300 Bio UV-vis spectrophotometer (Varian, Mulgrave, Victoria, 
Australia) was used to measure the absorption of permanganate solutions in a 
10 mm quartz cuvette. Sodium thiosulfate was added to the potassium 
permanganate solution containing polyphosphates, immediately prior to recording 
the first spectrum, and the mixture remained untouched until the final spectrum 
was recorded. 
 
  Sequential injection analysis (SIA) 
 A milliGAT pump (Global FIA, Fox Island, WA, USA) was used for 
sequential aspiration of permanganate reagent and analyte standards with a ten-
port multi-position valve (model C25Z, Valco, SGE, Melbourne, Victoria, 
Australia) and chemiluminescence detector. The detector comprised single-inlet 
serpentine flow cell (Global FIA) mounted flush against the window of a 
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photomultiplier tube (Electron Tubes model 9828SB; ETP) encased in a light tight 
housing and powered by a stable power supply at 900 V. A data acquisition board 
(LabJack U12, National Instruments, Victoria, Australia) and LabVIEW software 
(version 8.0, National Instruments) were used to control the pump and valve. 
Output from the photomultiplier tube was recorded using the e-corder 410 data 
acquisition system (eDAQ, Denistone East, NSW, Australia). This automated SIA 
system was programmed to repeatedly aspirate 150 μL of reagent (valve position 
1; 167 μL s-1), 1500 μL of the analyte standard (position 2; 167 μL s-1), and 1000 
μL of deionised water (position 3, 100 μL s-1), with a 60 min pause after every 5th 
cycle. 
  
Chapter Three 
40 
 
3. Results and Discussion 
  Characterisation of polyphosphate samples according to average 
chain length 
 Polyphosphate salts are used in various industrial applications, for instance 
in the processing of foods [162], due to their sequestering and dispersing properties 
[180]. Consequently, they are commercially available from many suppliers in 
numerous grades. In this study sixteen phosphate materials were obtained from five 
different suppliers, covering a wide range of specified chain lengths and grades. 
Each sample was characterised according to average chain length (n), using both 
modified end group titration and 31P nuclear magnetic resonance spectroscopy 
(NMR) [162, 182], with values ranging from 3.7 to 28.4.  
 Two modified end group titrations are shown in Figure 3.1 that represent 
the samples with the shortest and longest average chain lengths. Key differences 
were observed in the weak acid titration which measured the end group phosphates 
and orthophosphates, where a lower volume of base was required for the sample 
with longer average chain length. This is due to the lesser proportion of the end 
group phosphates in the longer chain sample, relative to those mixtures containing 
predominantly shorter oligomers. 
 The NMR data in Figure 3.2 shows distinction in the chemical shift and 
splitting in the end groups (between -5 and -11 ppm) and middle group (-19 and -
23 ppm), which give rise to differences in the peak integration. The results of the 
average chain length calculations using both the titration and NMR methodology 
were in good agreement for each of the 16 phosphate samples, and compared 
closely with the manufacturer specified values, as shown in Table 3.1. 
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(a)  
 
(b)  
 
Figure 3.1: Alkaline and weak acid titration curves used to calculate the average 
chain length of each polyphosphate sample in aqueous solution to the supplier 
specified values. 
(a) Polyphosphate, specified n = 4, (BassTech International);  
(b) Polyphosphate, specified n = 30, (BassTech International).
Alkaline 
titration 
Weak acid titration 
HCl added 
Weak acid 
titration 
Alkaline 
titration 
HCl added 
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(a)  
 
(b)  
 
Figure 3.2: 31P NMR spectra used to compare the average chain length of each 
polyphosphate sample in aqueous solution to the supplier specified values.  
(a) Polyphosphate, specified n = 4, (BassTech International);  
(b) Polyphosphate, specified n = 30, (BassTech International).   
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Table 3.1: Comparison of the average chain length classifications of each 
polyphosphate mixture according to the supplier specified values and data from 
titration and 31P NMR experiments. Following classification, a comparison was 
carried out of chemiluminescence intensity for the reaction of morphine 
(1 × 10- 6 M) and bisphenol A (1 × 10-5 M) with acidic potassium permanganate 
prepared with phosphate materials of different chain length. 
Phosphate/ 
polyphosphate 
supplier  
Grade Short chain phosphates 
Relative 
chemiluminescence 
intensitya 
Morphine  Bisphenol A  
UNIVAR - Orthophosphate (n =1) 0.01 0.00 
AnalaR - Pyrophosphate (n =2) 0.01 0.00 
Sigma-Aldrich - Tripolyphophate (n =3) 0.02 0.05 
Sigma-Aldrich - trimetaphosphate (cyclic) 0.00 0.05 
 
 Polyphosphates with average chain length (n) 
Relative 
chemiluminescence 
intensitya 
 Specified Titration  
31P 
NMR Morphine  
Bisphenol 
A  
Fibrisol - 4 3.7 4.0 0.54 0.29 
BassTech 
International Powder 4 4.0 4.4 0.90 0.81 
BassTech 
International Instantised 7 6.7 7.2 1.45 0.90 
Sigma-Aldrich +200 Mesh - 10.5 11.4 1.11 0.85 
Sigma-Aldrich +80 Mesh - 10.9 12.0 1.00 1.00 
BassTech 
International 
Cross-
linked - 14.4 13.9 1.46 1.24 
BassTech 
International Instantised 16 10.0 11.0 1.28 0.95 
BassTech 
International 
Coarse 
Powder 16 11.1 11.9 1.18 0.90 
Fibrisol - 14-18 16.1 15.0 1.14 1.00 
Sigma-Aldrich 65-70% P2O5 basis 
 - 15.8 16.3 1.02 0.95 
BassTech 
International Instantised 28 22.7 25.1 1.02 1.00 
BassTech 
International Instantised 30 25.7 28.4 1.22 1.00 
aEach reagent contained 1 × 10-3 M potassium permanganate and 0.1% m/v 
phosphate material, and was adjusted to pH 2.5 using sulfuric acid. Intensities are 
relative to those obtained using sodium polyphosphate (+80 mesh, crystals) from 
Sigma-Aldrich.  
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  The influence of average polyphosphate chain length on 
permanganate chemiluminescence intensity 
Previous studies that compared different polyphosphate materials for the 
enhancement of permanganate chemiluminescence found the response to be 
optimal when the average chain length was greater than 4 [62, 67, 87]. However, 
there is little understanding of the influence chain lengths beyond 4, as the materials 
are known to be complex mixtures of oligomers [181]. To further our understanding 
of the influence of the longer chain length, the chemiluminescence response as a 
function of n was compared via the permanganate reaction with morphine and 
bisphenol A. The relative chemiluminescence intensities shown in Table 3.1 were 
collected using flow injection analysis under previously optimised reagent 
conditions [184].  
As expected a weak response was observed from the linear, short-chain 
ortho-, pyro- and tri-phosphates (average chain lengths of 1, 2 and 3, respectively) 
and the cyclic trimetaphosphate samples [67]. The polyphosphates with an average 
chain length of greater than or equal to 7 all provided the strongest enhancement, 
with no significant difference between any of the materials. The two materials with 
average chain lengths of 4 gave an intermediate level enhancement, however it is 
interesting to note the degree of enhancement from the mixtures varied by a factor 
of ca. 2.5, under otherwise identical conditions. 
The experimental data observed in Table 3.1 was then corroborated by visual 
examination of the red emission from permanganate chemiluminescence. The 
photographs in Figure 3.3, recorded with a 92 second exposure time, show the 
emission emanating from the continuous merging of the reagent with a high 
concentration of morphine (1 × 10-3 M), in a coiled tubing flow-cell. 
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Figure 3.3: Photographs of chemiluminescence emission from the reaction of 
morphine (1 × 10-3 M) with the acidic potassium permanganate reagent in a coiled-
tubing flow-cell. The reactant solutions were continuously merged at a flow rate of 
3.5 mL min-1 per line. A 92 s exposure time was used for each photograph. Thanks 
to Donna Edwards (Deakin University) for the photography. 
(a) Orthophosphate n = 1 (UNIVAR);  
(b) Polyphosphate n = 4 (Fibrisol);  
(c) Polyphosphate n = 4 (BassTech International); 
(d) Polyphosphate n = 12 (Sigma-Aldrich, +80 mesh),  
 
  Polyphosphate oligomer distribution and its influence on 
permanganate chemiluminescence intensity 
Despite the classification of polyphosphate samples obtained from the titration and 
NMR data, there was no explanation for the difference in enhancement from the 
two mixtures with an n of 4. As ion chromatography has previously been utilised 
to examine the distribution of oligomers in polyphosphate mixtures [159-162, 185] 
a separation was adapted with the aim of exploring the possible differences between 
the two n = 4 mixtures. The ion chromatograms illustrated in Figure 3.4 reveal a 
number of differences in oligomer distribution between the two mixtures. 
 (a) (b) (c) 
(c) (d) (c) 
Chapter Three 
46 
 
(a)  
 
(b)  
 
Figure 3.4: Ion chromatograms for the two polyphosphate samples with a 
calculated average chain length of n = 4. The peaks that corresponded to phosphate 
chains of 1, 2 and 3 are labelled on each chromatogram and had retention times of 
1.8, 3.1 and 5.2 min, respectively, determined with standards. Peaks corresponding 
to oligomers with longer polyphosphate chain lengths that could be confidently 
identified using the procedure by Ohtomo and co-workers [161] are labelled in each 
Figure. The two chromatograms represent the polyphosphate samples as follows: 
(a) Polyphosphate n = 4 (Fibrisol);  
(b) Polyphosphate n = 4 (BassTech International), which gave the best  
chemiluminescence enhancement of the two mixtures.
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The approach by Ohtomo and co-workers [161] was used to identify the 
chain length of polyphosphate species separated via ion chromatography by fitting 
a logarithmic curve based on the retention times of the orthophosphate, 
pyrophosphate and triphosphate standards. Comparing the distribution of oligomers 
between the two samples showed that mixture that gave greater chemiluminescence 
enhancement (BassTech International) had a wider distribution of long chain 
oligomers with 10 or more repeating phosphate units. While these long chain 
oligomers are not necessarily involved directly in the enhancement mechanism (as 
they are not present orthophosphate, pyrophosphate or triphosphate materials, 
which still enhance) their presence increases the complexity of the mixture. This in 
turn provides further options for both interaction between the enhancer components 
and the chemiluminescence reaction pathway and a higher concentration of the 
important oligomers.  
The oligomer distributions of the remaining 14 polyphosphate samples were 
examined using ion chromatography, in order to determine further differences. 
Figure 3.5 and 3.6 show three materials with n ൒ 12, which illustrated a general 
trend of more complex oligomer distributions as n increased. Despite the wider 
oligomer distributions, each of these samples provided a comparable enhancement 
of chemiluminescence. The ion chromatography data from these and the two n = 4 
samples therefore suggests that maximum chemiluminescence intensity is 
independent of average chain length, once a sufficient concentration of oligomers 
with approximately 7 or more phosphate units are present.  
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(a)  
 
(b)  
 
Figure 3.5: Ion chromatograms for (a) polyphosphate n = 12, +80 mesh crystals 
from Sigma Aldrich and (b) polyphosphate n = 16, Budit 3H from BassTech 
International. The peaks that corresponded to phosphate chains of 1, 2 and 3 are 
labelled on each chromatogram, and had retention times of 1.8, 3.1 and 5.2 min 
respectively, determined with standards. Peaks corresponding to oligomers with 
longer polyphosphate chain lengths that could be confidently identified using the 
procedure by Ohtomo and co-workers [161] are labelled in each Figure.  
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Figure 3.6: Ion chromatogram for polyphosphate n = 30, Budit 4H from BassTech 
International. The peaks that corresponded to phosphate chains of 1, 2 and 3 are 
labelled and had retention times of 1.8, 3.1 and 5.2 min respectively, determined 
with standards. Peaks corresponding to oligomers with longer polyphosphate chain 
lengths that could be confidently identified using the procedure by Ohtomo and co-
workers [161] are also labelled.  
 
  The changing retention behaviour of polyphosphate oligomers in the 
presence of Mn(II) 
 According to the dual mechanism postulated by Hindson and co-workers 
[89], polyphosphates enhance the emission from acidic potassium permanganate 
chemiluminescence by stabilising the Mn(III) precursor and forming protective 
“cage-like” structures around the Mn(II) emitter. Whilst we now understand that a 
wide distribution of long chain oligomers is required for optimal enhancement, 
identifying those which are most important is a difficult endeavour, given the 
complexity of the mixtures and the lack of pure materials available with an n ൒4. 
Furthermore, the reaction is fast and the key intermediates are short lived [76].  
 To investigate the oligomer(s) that may interact with Mn(II), a selection of 
the polyphosphate samples were mixed with Mn(II) and separated via ion 
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chromatography. This time, in place of conductivity, an inductively coupled 
plasma-mass spectrometer (ICP-MS) was used for detection in order to monitor the 
column eluate for 31 amu (phosphorus) and 55 amu (manganese). When mixed at 
the correct pH, positively charged Mn(II) ions are expected to complex with 
negatively charged polyphosphate oligomers, and separate according to the overall 
charge of the complex. Shared retention times for manganese and phosphate may 
indicate attraction between the two species, and allow identification of the 
oligomers which are interacting. Figure 3.7 shows two representative ICP-MS 
chromatograms for the separation of polyphosphate mixtures (n = 7 and n = 12) in 
the presence of Mn(II).  
 Each of the chromatograms shows has more than one manganese peak, 
suggesting that complexes form with many of the polyphosphate oligomers. In the 
case of the n = 7 sample, manganese is detected at the same retention time as many 
of oligomers with 2 or more repeating phosphate units. Whilst this information 
affirms the hypothesis that multiple oligomers may be of importance for forming 
Mn(II)-polyphosphate complexes, identifying their chain lengths is uncertain. The 
Ohtomo method [161] was applied with caution as the presence of Mn(II) reduces 
the charge of oligomers changing their retention and elution order, which is the 
likely explanation for the early eluting manganese peak in the n = 12 mixture. 
Nonetheless, the retention times were used to compare the changes in relative area 
of each polyphosphate peak both on its own and in the presence of Mn(II). 
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(a)  
 
 
(b)  
 
Figure 3.7: Chromatograms showing the elution of phosphorus (31 amu) and 
manganese (55 amu), recorded using ICP-MS following separation via anion 
chromatography. 
(a) Polyphosphate n = 7 (BassTech International); 
(b) Polyphosphate n = 12 (+80 mesh, Sigma-Aldrich). 
 
 For each of the polyphosphates compared, the area of later eluting peaks 
showed a decrease in the presence of Mn(II), with corresponding increases for the 
less strongly retained species. These changes in area suggested the oligomers were 
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eluting earlier after the addition of Mn(II) and formation of Mn(II)-polyphosphate 
complexes. While the changing elution made identification of specific oligomers 
difficult, the results supported earlier findings in this chapter regarding the 
importance of having long chain polyphosphates present. This helps to account for 
the differences in enhancement provided by the two n = 4 samples, and indicates 
that multiple oligomers are probably involved in the enhancement of permanganate 
chemiluminescence. 
 
  The relationship between polyphosphate chain length and 
concentration for optimal enhancement 
 The wide distribution of oligomers observed in each of the polyphosphate 
mixtures may also explain why a large excess of polyphosphates is typically 
required for the optimum enhancement in chemiluminescence intensity [89, 184]. 
For example when comparing the differences in the enhancement between the n = 
4 samples, at the levels examined the mixture giving the highest enhancement 
contained a higher concentration of the longer chain oligomers most important in 
the reaction.  
 To compare the influence of average chain length on the polyphosphate 
concentration required for maximum enhancement, permanganate 
chemiluminescence intensities were examined using polyphosphates at levels 
between 0.0001% and 1% (m/v). The results in Figure 3.8 show that for materials 
with n = 11, 14 and 30, optimal chemical intensities were achieved at 0.01% (m/v) 
and 0.1% (m/v) polyphosphate for morphine and bisphenol A, respectively.  
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(a)  
 
(b)  
 
Figure 3.8: The influence of polyphosphate concentration on chemiluminescence 
intensity for the polyphosphate samples: polyphosphate n = 4 (Fibrisol), red; 
polyphosphate n = 12, +200 mesh, black (Sigma Aldrich); polyphosphate n = 16, 
Budit 3H, purple (BassTech International); and polyphosphate n = 30, green 
(BassTech International); when reacted with (a) morphine and (b) bisphenol A. 
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  In comparison, the shorter n = 4 (Fibrisol) material required a concentration 
5- to 10-fold higher for maximum enhancement, most likely to provide sufficient 
levels of the longer chain oligomers. Nonetheless, even at higher concentrations, 
the n = 4 (Fibrisol) sample did not provide an enhancement in chemiluminescence 
intensity comparable to the polyphosphate materials with longer average chain 
lengths. These results also suggest that, for some analytes, the optimal 
polyphosphate concentrations may be considerably lower than the quantities used 
in previous publications [62, 86].  
 
  Chain length dependent polyphosphate stability 
 The stability of acidic potassium permanganate solutions containing sodium 
polyphosphate is limited by both degradation of the oxidant and the pH dependent 
hydrolysis of the enhancer [186, 187]. Hydrolytic degradation of linear 
polyphosphates (leading to random scission along the chains to form shorter linear 
chains and ring structures) is most rapid under basic and mildly acidic conditions 
[181, 188]. The hydrolytic degradation of linear polyphosphates was monitored 
over time by using 31P NMR to measure the reduction in the average chain length 
of two mixtures. They were prepared in aqueous media at pH 2.5 as per the 
conventional chemiluminescence reagent solution, and at a neutral pH and 
degradation monitored over 48 hours. The results are summarised in Table 3.2.
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Table 3.2: The change in average polyphosphate chain length monitored over 48 
hours using 31P NMR under neutral and acidic (reagent) conditions, for an 
intermediatea and a longb chain polyphosphate. 
 t = 0 t = 3 hr t = 24 hr t = 48 hr Total change 
Neutral 12.0
a 12.0a 12.2a 12.2a 1.4%a 
28.4b 30.2b 28.4b 28.3b -0.4%b 
Acidic 
(pH 2.5) 
12.0a 11.6a 11.4a 11.4a -4.9%a 
29.0b 27.9b 26.7b 24.6b -14.9%b 
 
 
 Over 48 hours, the samples were more stable at neutral pH, with the average 
chain length changing by less than 1.5% for each sample, consistent with previous 
studies [181]. At pH 2.5 the longer (n = 30) chain polyphosphate degraded more 
than the intermediate (n = 12) chain material, with the former showing a 15% 
reduction in average chain length, and the latter undergoing a 5% reduction. 
Typically permanganate chemiluminescence reagents are prepared fresh daily to 
circumvent the effects of degradation. Nonetheless for maximum signal 
enhancement the shorter average chain length polyphosphates are a better choice 
for a greater stability. It is important to ensure the polyphosphate selected has an 
average chain length greater than the minimum of n = 7 (Table 3.1). 
 
  The dependence of reagent stability on polyphosphate chain length 
and concentration 
The influence of polyphosphate chain length on stability of permanganate 
reagent was analysed by monitoring the visible absorbance of manganese(VII) (at 
525 nm) in the reagent over time. A recently reported ‘enhanced’ form of the 
reagent, in which a large portion of the oxidant is initially reduced to Mn(III) [76] 
was examined in addition to the conventional form already used in this chapter. The 
enhanced form of the reagent reacts at a much faster rate with some analytes, 
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increasing the emission intensities by up to two-orders of magnitude [76]. 
However, it is heavily reliant on the presence of polyphosphates for stability, to 
prevent the conversion of the Mn(III) to Mn(IV) and Mn(II), thus it is more 
sensitive to their degradation [76].  
The Mn(III) enhanced reagent was prepared as previously described [76] 
using a higher initial concentration of permanganate (1.9 mM) that was partially 
reduced to Mn(III) by sodium thiosulfate (1 mM), immediately prior to measuring 
the structured absorbance bands of permanganate. The changing Mn(IV) 
absorbance was studied using polyphosphates of n = 4 (BassTech International), 7, 
16 and 30 at concentrations of 0.01% m/v, 0.1% m/v and 1% m/v. Figure 3.9 shows 
the spectrum for the n = 4 sample at 0.1% m/v polyphosphate.  
 
 
Figure 3.9: A representative ultra-violet and visible absorbance spectra between 
400 and 650 nm, illustrating the change over 90 min for the Mn(III) enhanced 
reagent containing 0.1% m/v of the n = 4 (BassTech International) polyphosphate 
material. The first spectrum is in bold, every 5th spectrum is shown and the arrow 
indicates the direction of change from the first to last spectrum. 
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The low 0.01% m/v concentration was not sufficient to stabilise the 
enhanced reagent form, which was observed through the immediate loss of the 
characteristic purple colour of permanganate and generation of a brown Mn(IV) 
suspension. At 0.1% m/v each of the polyphosphate materials were capable of 
initially stabilising the reagent upon the addition of thiosulfate, however a 
significant increase was observed in the absorption at 450 nm after only 80 min, 
attributable to the formation of Mn(IV) [25].  
The change in Mn(IV) absorbance over time for each of the mixtures at 
0.1% m/v polyphosphate concentration is shown in Figure 3.10a. The enhanced 
reagent solutions containing 1% m/v of the longer chain polyphosphates were 
reasonably stable over 48 hours, showing almost no change in the absorbance of 
the Mn(IV) band at 450 nm (Figure 3.10b).  
A 48 hour degradation study was then carried out to compare the importance 
of polyphosphate concentration on the stability of the Mn(III) enhanced reagent 
[18], to that of the conventional form with (0.5 mM KMnO4, 1% m/v sodium 
polyphosphate, adjusted to pH 2.5). The n = 12 +80 mesh sodium polyphosphate 
sample from Sigma Aldrich was used and in agreement with previous work both 
forms of the reagent were quite stable over 48 hours [76]. Whilst the enhanced 
reagent required a larger concentration of polyphosphate, and was less stable, only 
a small decrease in the absorbance of the permanganate band at 525 nm and minor 
increase in the Mn(IV) absorption at 425 nm was observed (Figure 3.11).  
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(a)  
 
 
(b)  
 
Figure 3.10: Plots monitoring change in absorbance over 48 hours at 450 nm to 
monitor the formation of Mn(IV) in the enhanced reagent [28] for two 
polyphosphate concentrations: (a) 0.1% and (b) 1%. The change in absorbance 
allows assessment of the stability of the reagent containing polyphosphates with n 
= 4; n = 7; n = 12 and n = 30, from Bass Tech International.  
Time zero for the stability data was measured immediately after the addition of 
sodium thiosulfate to the polyphosphate containing permanganate solutions.  
Chapter Three 
59 
 
(a)  
 
(b)  
 
Figure 3.11: Typical absorption spectra collected every 90 min over 48 hours to 
monitor the stability of (a) conventional acidic potassium permanganate reagent 
(5.0 × 10-4 M KMnO4, pH 2.5) containing 0.01% (m/v) sodium polyphosphate (n 
= 12, Sigma-Aldrich); and (b) ‘enhanced’ acidic potassium permanganate reagent 
(1.9 × 10-3 M KMnO4, pH 2.5, 1.0 × 10-3 M Na2S2O3) containing 1% (m/v) sodium 
polyphosphate (n = 12, Sigma-Aldrich).  
In each case the first spectrum is in bold and every 5th spectrum is shown (in Figure 
3.11b the arrow indicates the direction of change from the first to last spectrum).  
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To complete the polyphosphate chain length dependent stability analysis, 
chemiluminescence intensity was monitored from the reaction between acidic 
potassium permanganate (with thiosulfate) and morphine over time. Sequential 
injection methodology was used to perform a set of five replicate morphine 
injections each hour over 48 hours for a short (n = 4, BassTech International), 
intermediate (n = 12, +80 mesh, Sigma-Aldrich) and long chain (n = 30, BassTech 
International) polyphosphate sample (Figure 3.12).  
The chemiluminescence intensity for the reagent containing the shorter 
chain (n = 4) polyphosphate was found to decrease by 11% over 48 hours (RSD of 
49 sets of 5 replicates was 4%), whereas the intensities for the intermediate (n = 12) 
and long chain (n = 30) polyphosphates increased by 14% and 3% (RSD of 49 sets 
of 5 replicates was 7% and 11%), respectively. The results of the sequential 
injection analysis support the findings of the UV absorbance experiments, 
indicating that any degradation of the polyphosphates over 48 hours has only a 
minor impact on chemiluminescence enhancement. 
 
 
Chapter Three 
61 
 
 
Figure 3.12: Chemiluminescence intensity versus time plot showing change in 
response for a series of five replicate morphine (1 × 10-6 M) injections every hour 
over 48 hours, collected using sequential injection methodology.  
The Mn(III) enhanced acidic potassium permanganate (1.9 × 10-3 M, pH 2.5) 
reagent was used, with the following polyphosphate samples: n = 4, blue (BassTech 
International); n = 12, +80 mesh, black, (Sigma-Aldrich); and n = 30, orange 
(BassTech International).  
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4. Conclusions 
 Although there was a minimum polyphosphate chain length (~7) required 
for significant enhancement of permanganate chemiluminescence no advantage 
was obtained using polyphosphate materials with much longer average chain 
lengths. Longer chain polyphosphates degraded faster than their medium chain 
counterparts under analytical conditions (pH 2.5), but at the concentrations used, 
only a minor reduction in chemiluminescence intensity was observed over 
48 hours. 
 Average chain length provided a convenient characterisation of 
polyphosphate materials, but those with similar values can exhibit markedly 
different distributions of individual oligomers, as shown when separated using ion 
chromatography. The effects of the different oligomer distributions was most 
profound for the two n = 4 polyphosphates, which gave significantly different 
chemiluminescence intensities under otherwise identical conditions. Despite 
tracking the changes in oligomer distributions between samples, the 
polyphosphates required for optimal enhancement could not be confidently 
identified, due to the complexity of the mixtures. 
 Providing the material has a sufficient average chain length, the optimum 
concentration of polyphosphate in the permanganate reagent was dependent on the 
target analyte, and may be lower than the quantities listed in previous reports. 
However, the concentration of polyphosphate cannot be lowered in permanganate 
reagents that have been partially reduced to generate high concomitant levels of 
Mn(III), due to the greater need to stabilise this key intermediate and prevent the 
formation of insoluble Mn(IV). 
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Chapter Four 
 
Determination of neurotransmitters and their metabolites using 
one- and two- dimensional liquid chromatography with acidic 
potassium permanganate chemiluminescence detection 
 
1. Introduction 
 Some previous reports on the separation of neurotransmitters, and their 
metabolites, using 2D-HPLC indicate that this approach may be advantageous for 
this class of compounds and further investigation is warranted [189-191]. Eggink 
and co-workers [191] developed a comprehensive 2D-HPLC approach with UV-
absorbance and mass spectrometric detection for complex biological samples using 
a test-set of 32 compounds that included the neurotransmitter dopamine. Their 
paper was primarily focussed on method development and although the procedure 
was applied to one urine sample, no attempt was made at quantifying any of the 
separated compounds [191]. Anderson and co-workers utilised 2D-HPLC with 
targeted fraction collection (heart-cutting) from the first dimension to determine the 
metabolites 4-hydroxy-3-methoxyphenyl glycol [190] or homovanillic acid and 
5- hydroxyindole-3-acetic acid [189] in urine with electrochemical (amperometric) 
detection. 
 Electrochemical detection is the most commonly used detector for the 
determination of neurotransmitters and their metabolites [14, 192-194]. However, 
there are limitations such as deposition of oxidation products on the electrode 
surface necessitating electrode cleaning, the restricted use of ion-pairing reagents, 
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and an inability to handle changes in mobile phase composition [195, 196] that can 
make its routine application troublesome [196]. Chemiluminescence detection with 
acidic potassium permanganate is an attractive alternative due to its simple reagent 
manifold, high reproducibility, excellent compatibility with mobile phase gradients 
of most common solvent compositions and sensitivity towards the target analytes 
[62, 77-80].  
 Pioneering work by Adcock and co-workers [47] has demonstrated the 
rapid one-dimensional HPLC determination of neurotransmitter metabolites in 
urine using a monolithic column and acidic potassium permanganate 
chemiluminescence detection. However in the aforementioned application, 4-
hydroxy-3- methoxyphenyl glycol and vanilmandelic acid co-eluted with unknown 
interfering compounds present in the urine and the number of observed peaks 
suggested possible co-elution of minor sample components with the other analytes 
[47]. This chapter explores the determination of neurotransmitters and their 
metabolites in rat brain and human urine using one and two-dimensional liquid 
chromatography coupled with acidic potassium permanganate chemiluminescence 
detection. 
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2. Experimental 
  Solvents and standards 
 Norepinephrine hydrochloride, normetanephrine hydrochloride, DOPAC, 
5-HIAA, VMA, trifluoroacetic acid (99%), sodium polyphosphate (+80 mesh, 
96%) and sodium thiosulfate (≥ 98%) were purchased from Sigma-Aldrich (Castle 
Hill, NSW, Australia). Dopamine hydrochloride was from Alfa Aesar 
(BioScientific Pty. Ltd. Gymea, NSW, Australia). Potassium permanganate (AR 
Grade), hydrochloric acid (32% w/w), ethanol (≥ 99.5% v/v), propanol (≥ 99.5% 
v/v), butan-1-ol and formaldehyde (≥ 37% w/w) were obtained from Chem Supply 
(Gilman, SA, Australia). Sulfuric acid (98%) was supplied by Merck (Kilsyth, 
Victoria, Australia). HPLC grade methanol was supplied by Ajax (Tarren Point, 
NSW, Australia).  
 
  Flow injection analysis (FIA) 
 The analytes were injected (70 μL) on a simple two-line FIA manifold with 
an automated six-port valve (Valco Instruments, Houston, TX, USA) into a 
deionised water carrier stream, which merged at a T-piece with the acidic 
potassium permanganate reagent prior to entering a coiled-tubing detection flow-
cell comprising 0.8 mm i.d. PTFE tubing (DKSH, Caboolture, Queensland, 
Australia). When an enhancer was used, it was merged with the carrier steam, 
which was then combined with the reagent via the T-piece described above. The 
carrier and reagent lines were propelled through 0.8 mm i.d. PTFE tubing (DKSH) 
at 4 mL min-1 using a peristaltic pump (Gilson Minipuls 3, John Morris Scientific, 
Balwyn, Victoria, Australia) with bridged PVC tubing (DKSH). The flow-cell was 
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mounted flush against the window of a photomultiplier tube (Electron Tubes model 
9828SB; ETP, NSW, Australia) encased in a light tight housing and powered by a 
stable power supply at 950 V. Chemiluminescence intensities were documented 
with a chart recorder (YEW type 3066, Yokogawa Hokushin Electric, Tokyo, 
Japan) and the peak heights were measured manually. 
 
  HPLC 
 Chromatographic analysis was carried out using an Agilent Technologies 
1260 Series liquid chromatography system, equipped with a quaternary pump 
(incorporating a vacuum degasser), column thermostat, diode array detector and 
autosampler (Agilent Technologies, Victoria, Australia). Agilent Chemstation 
software was used for system control and data acquisition. Chemiluminescence 
detection was employed via the FIA manifold, by replacing the carrier stream (and 
injection valve) with the eluate line from the column. The chemiluminescence 
reagent and formaldehyde solutions were propelled at 1 mL min-1 using two Model 
12-6 Dual Piston Pumps (Scientific Systems, PA, USA). A Hewlett-Packard 
35900E analogue to digital converter was used to convert detector signals (Agilent 
Technologies).  
 One-dimensional separations were carried out using a Synergi Hydro-RP 
column 80 Å pore diameter, 4 μm particle diameter; 250 × 4.6 mm column 
dimensions (Phenomenex, Lane Cove, NSW, Australia) fitted with a C18 guard 
column. A 20 μL injection volume and mobile phase flow rate of 0.8 mL min-1 were 
used for the separation. Brain samples were separated using an aqueous 
trifluoroacetic acid (pH 2.15)/methanol mobile phase gradient. Following injection, 
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0% methanol was held for 5 min, increased linearly over 9 min to 10%, before 
increasing to 32% methanol over the next 11 min, for a total 25 min analysis time. 
The column was then flushed with methanol and re-equilibrated to the initial mobile 
phase composition with a minimum of three column volumes of mobile phase prior 
to subsequent analyses. One-dimensional separations of urine were performed 
using the same mobile phases as for brain samples, initially at 0% methanol for 
5 min, increased linearly to 10% over 9 min, then increased to 55% methanol over 
the next 21 min, for a total 35 min analysis time. The column was then flushed with 
methanol and re-equilibrated between each separation.  
 Liquid chromatography mass spectrometry was carried out using an Agilent 
Technologies LC/MSD TOF mass spectrometer under the following conditions; 
drying gas: nitrogen (7 L min-1, 350 °C), nebulizer gas: nitrogen (16 psi), capillary 
voltage: 4.0 kV, vaporiser temperature: 350 °C, cone voltage: 60 V. MS data 
acquisition was carried out using MassHunter Workstation Acquisition for TOF/Q-
TOF and data analysis carried out using MassHunter Qualitative Analysis. The 
separation was carried out as described above. 
 
  2D-HPLC 
 The sample characterisation 2D-HPLC separation was carried out using the 
Agilent 1260 series system described, in the offline heart cutting mode, where the 
first dimension injection was performed once and sequential fractions were 
collected using a fraction collector before they were sequentially reinjected onto 
the second dimension. The first dimension separation was carried out using the 
Synergi Hydro-RP column used for the one dimensional brain and urine 
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separations, with an injection volume of 100 μL and mobile phase flow rate of 
0.8 mL min-1. The mobile phase was operated in gradient mode with an initial 
composition of 10% methanol in water (trifluoroacetic acid was added to both 
solvent reservoirs at a concentration of 0.1% v/v) that increased linearly to 90% 
methanol over 10 minutes and held isocratically for a further 2 minutes. Sequential 
200 μL eluent fractions were collected using a programmable Gilson FC204 
fraction collector (Gilson, Middleton, WI, USA) between 5 and 10.5 minutes (total 
of 22 fractions).  
 The second dimension was carried out using a Luna cyano column (5 μm 
particle diameter; 150 × 4.6 mm column dimensions, Phenomenex), with an 
injection volume of 100 μL and mobile phase flow rate of 1.0 mL min-1. A mobile 
phase gradient was again employed, which was held isocratic at 5% methanol in 
water for the first 5 minutes, then linearly increased to 90% over the next 5 minutes, 
held for a further 2 minutes, before 5 minutes under original conditions for 
re- equilibration. Additional columns included in the stationary phase selectivity 
study included: an Agilent Zorbax Eclipse AAA column (3.5 μm particle diameter; 
150 × 4.6 mm column dimensions, Agilent Technologies, Mulgrave, Victoria, 
Australia), an Agilent C18 XDB column (5 μm particle diameter; 150 × 4.6 mm 
column dimensions, Agilent), a Synergi Polar-RP  column (80 Å pore diameter, 
4 μm particle diameter; 150 × 2 mm column dimensions, Phenomenex, Lane Cove, 
NSW), an Aqua C18 column (125 Å pore diameter, 3 μm particle diameter; 150 × 
2.0 mm column dimensions, Phenomenex), a Luna NH2 column (100 Å pore 
diameter, 5 μm particle diameter; 150 × 4.6 mm column dimensions, Phenomenex), 
and an Aqua C18 column (200 Å pore diameter, 5 μm particle diameter; 150 × 
2.0 mm column dimensions, Phenomenex); and a Chromalith Performance 100-
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3 mm, RP 18e column (100 × 3 mm column dimensions, Merck, Kilsyth, Victoria, 
Australia). 
 For the shorter targeted analysis 2D-HPLC method, separations were 
completed for each target compound in the heart-cutting mode, where the sample 
was injected onto the first dimension for each target, then both dimensions were 
completed and re-equilibrated prior to following injections. The analysis was 
performed with the Agilent system and chemiluminescence detector (described 
above) with the addition of a 1260 series quaternary pump and column thermostat 
(Agilent Technologies) to operate the second dimension. The first dimension 
separation was conducted with a Poroshell 120 cyano column (2.7 μm particle 
diameter; 100 × 4.6 mm column dimensions, Agilent Technologies), with an 
injection volume of 100 μL and mobile phase flow rate of 1.0 mL min-1. The mobile 
phase was operated in gradient mode with an initial composition of 5% methanol 
in water (trifluoroacetic acid was added to both solvent reservoirs at a concentration 
of 0.1% v/v), that increased in a single step to 50% methanol over 8 min; the system 
was re-equilibrated for 4.5 minutes. Fractions were transferred to the second 
dimension via a 100 μL sample loop and a ten-port, two-position switching valve 
(Agilent Technologies). The switching valve was activated at times established 
using the above separation and five standards of interest (i.e., five fractions were 
cut to the second dimension).  
 The second dimension was performed on a Poroshell 120 C18 column 
(2.7 μm particle diameter; 100 × 4.6 mm column dimensions; Agilent 
Technologies), with a mobile phase flow rate of 3 mL min-1 and column 
temperature of 47.5 °C. The mobile phase was initially 5% methanol in water 
(0.1% v/v trifluoroacetic acid) and increased to 26% methanol over 5.5 minutes. 
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The re-equilibration time was 2.5 minutes and the total sample analysis time was 
62.5 minutes. Each standard mixture and sample was run in triplicate.  
 Prior to data analysis, baselines were corrected using a parameterised least 
squares smoothing filter [197]. Two-dimensional chromatographic data recorded 
by ChemStation was then imported to Wolfram Mathematica 9 (distributed by 
Hearn Scientific Software, Melbourne, Victoria, Australia) and converted to two-
dimensional surface plots, which distinguish peaks of different intensities using a 
hot to cold colour gradient [198]. 
 
  Preparation of rat brain 
 Rats were sacrificed and the whole brains were snap frozen in liquid 
nitrogen and stored at െ80 °C until use. The cutting board and tools were cooled in 
liquid nitrogen. Brain samples were defrosted and the prefrontal cortex, nucleus 
accumbens and hippocampus regions removed and dissected into left and right 
hemispheres on a sanitized metal tray securely fitted over a bath of ice. Samples 
were homogenised in an aqueous trifluoroacetic acid solution (pH 2.15; 1.5 mL for 
hippocampus and prefrontal cortex and 1.0 mL for nucleus accumbens) using a 
hand held homogeniser on slow setting (Pro Scientific, Oxford, CT, USA). 
Homogenates were then centrifuged for 10 min at 14,000 g at 4 °C. The supernatant 
was then removed and samples stored at െ20 °C until analysis and diluted two-fold 
in the trifluoroacetic acid solution. 
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  Preparation of human urine 
 Fresh urine samples were collected and analysed on the same day. 
Immediately after collection, the samples were preserved by adding a 7.5 M 
hydrochloric acid solution (50 PL per 1 mL of urine) and storing at 4 °C. Prior to 
analysis, the sample was diluted 10-fold with deionised water and filtered using a 
0.45 μm syringe filter. To confirm retention times, the sample was spiked with 
higher concentrations of the analytes by aspirating both sample and standard 
solutions into the needle of the autosampler for injection onto the HPLC column. 
 
  Acidic potassium permanganate reagent 
 The permanganate reagent was prepared daily by dissolution of sodium 
polyphosphate in deionised water, adding potassium permanganate and adjusting 
to pH 2.5 using sulfuric acid. Sodium thiosulfate was added as required (following 
pH adjustment) using an appropriate volume of a 0.1 M solution.  
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3. Results and Discussion 
  Development of a separation for rat brain samples 
 A selection of six important neurotransmitter and metabolite standards were 
used for development of a one dimensional separation using a Phenomenex Synergi 
Hydro-RP column, selected for its enhanced retention of compounds with high 
polarity. The detection of norepinephrine, dopamine, serotonin, epinephrine, 3,4-
dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid was achieved using 
previously optimised acidic potassium permanganate chemiluminescence 
conditions [47] prior to carrying out a reagent optimisation specific to these 
analytes [80]. It is noted that methanol increases the background noise level of the 
permanganate chemiluminescence signal, especially in the presence of 
formaldehyde, resulting in baseline variations for the following chromatograms as 
its concentration is altered in the mobile phase [79]. 
 Baseline resolution of each of the standards was initially achieved in under 
nine minutes, however when the method was applied to the brain sample, non-
analyte components of the sample were found to co-elute with norepinephrine 
(Figure 4.1). Therefore to obtain baseline resolution of each neurotransmitter 
analyte in the brain samples, the gradient was expanded, resulting in retention times 
of 5.9, 15.8, 23.1 and 31.9 minutes for norepinephrine, dopamine, serotonin and 
homovanillic acid, respectively (Figure 4.2). Whilst baseline resolution was 
obtained, the weak chemiluminescence signals illustrated a need for an 
optimisation of the reagent conditions to improve sensitivity.  
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(a) 
 
(b) 
 
Figure 4.1: Chromatograms showing the separation of: (a) neurotransmitter 
standards norepinephrine (NE), dopamine (DA), serotonin (5-HT) and 
homovanillic acid (HVA); and (b) a rat brain sample on a Synergi Hydro-RP 
column with acidic potassium permanganate chemiluminescence detection. Co-
elution of the norepinephrine analyte showed a need for further optimisation. 
NE DA 
5-HT 
DOPAC 5-HIAA 
HVA 
NE  
(co-elution) 
DA 
5-HT 
HVA 
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(a) 
 
(b) 
 
Figure 4.2: Optimised separation of (a) neurotransmitter and metabolite standards 
(with formaldehyde reagent enhancer); and (b) a brain sample (without 
formaldehyde) on the Synergi Hydro-RP column highlighting resolution of each 
analyte from matrix components of the sample.   
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  Acidic potassium permanganate reagent optimisation for 
neurotransmitter detection 
 A flow injection analysis manifold with a chemiluminescence detector was 
used to compare the emission arising from the oxidation of norepinephrine, 
dopamine and serotonin under a range of permanganate reagent conditions to 
determine which provided the greatest sensitivity. This reagent study employed 
sodium thiosulfate and formaldehyde as signal enhancers as previous work 
demonstrated a significant increase in emission from the oxidation of phenols that 
were structurally similar to the neurotransmitters of interest in this chapter [76, 80].  
 Formaldehyde is however a carcinogen (by inhalation), leading to safety 
concerns for the user and problems in ordering, storage and disposal [199]. Primary 
alcohols (methanol, ethanol, propanol and butanol) were evaluated for their 
potential as alternative enhancers to formaldehyde as their presence has also been 
shown to produce higher emission intensities from catecholamines (albeit with an 
increase in background noise) [79] (Figure 4.3). The optimal conditions for each 
neurotransmitter varied somewhat, however a suitable compromise was reached for 
the ideal sensitivity of each analyte in a single chromatographic run. Although the 
chemiluminescence intensity for each analyte was influenced by reagent pH and 
the concentration of permanganate and polyphosphate, the addition of 
formaldehyde had the biggest effect on emission intensity, significantly greater 
than the enhancement given by sodium thiosulfate or the primary alcohols. 
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Figure 4.3: Chemiluminescence intensity using different permanganate reagent conditions for the detection of norepinephrine (green), 
dopamine (orange) and serotonin (purple) at 1 × 10-5 M. Reagent conditions are as follows:  
Reagents A-B: 1 mM KMnO4, 1% (m/v) sodium polyphosphate, using (A) pH 2.5, or (B) pH 2.5 and ethanol enhancer. 
Reagents C-I: 1 mM KMnO4, 1.5% (m/v) sodium polyphosphate, using (C) pH 2.5, (D) pH 2.5, ethanol, (E) pH 2.5, propanol, (F) pH 
2.0, propanol, (G) pH 2.5, butanol, (H) pH 2.5, 2 M formaldehyde, (I) pH 2.0, 2 M formaldehyde.  
Reagents J-Q: 1.9 mM KMnO4, 1 mM Na2S2O3, 1.5% (m/v) sodium polyphosphate, using (J) pH 2.5, (K) pH 2.5, methanol, (L) pH 
2.5, ethanol, (M) pH 2.5, propanol, (N) pH 2.0, propanol, (O) pH 2.5, butanol, (P) pH 2.5, 2 M formaldehyde, and (Q) pH 2.0, 2M 
formaldehyde.
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 A set of optimised conditions for the three standards (Set I in Figure 4.1: 
1 mM KMnO4, 1.5% m/v sodium polyphosphate, adjusted to pH 2.0, and 2 M 
formaldehyde) were selected and transferred to the HPLC system. The reagent flow 
rate was optimised (1.0 mL min-1) and the limits of detection (S/N = 3) for each 
neurotransmitter were established and compared between UV absorbance (230 nm) 
and optimised chemiluminescence. The higher emission intensities for 
norepinephrine and dopamine translated to lower limits of detection relative to that 
of serotonin (Table 4.1). 
 
Table 4.1: Limits of detection (M) for the neurotransmitters and their metabolites, 
using HPLC with acidic potassium permanganate chemiluminescence (S/N = 3) 
compared to UV absorbance at 230 nm. Reagent conditions for the detection of 
neurotransmitters: 1 mM KMnO4, 1.5% m/v sodium polyphosphate, adjusted to pH 
2.0, and 2 M formaldehyde (Set I in Figure 4.3).  
 
 Norepinephrine Dopamine Serotonin 
Permanganate 
Chemiluminescence 2.5 × 10
-8 5 × 10-8 1 × 10-7 
UV absorbance 1.0 × 10-6  2.5 × 10-6 1 × 10-7 
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  Determination of catecholamine neurotransmitters in brain samples 
 Rat brain tissue was sourced from two animals for the determination of the 
parent neurotransmitters using the above optimised reagent conditions (Figure 4.4). 
Spiking brain samples with neurotransmitter standards confirmed the retention of 
each analyte in the chromatogram. In these samples, serotonin levels were not 
observed above the limit of detection. To quantify norepinephrine and dopamine 
across three key brain regions (the nucleus accumbens, prefrontal cortex, and 
hippocampus) a linear calibration for each was prepared using five standard 
solutions between 1 × 10-7 M and 7 × 10-7 M (R2 = 0.992 for norepinephrine and 
0.997 for dopamine). As shown in Table 4.2, there was a variation in 
neurotransmitter levels between both the brain regions and the left and right 
hemispheres. 
 
 
Figure 4.4: Chromatogram showing the separation of neurotransmitters extracted 
from the left nucleus accumbens region of a rat brain sample, with norepinephrine 
(NE) and dopamine (DA) peaks identified, using permanganate 
chemiluminescence detection (1 mM KMnO4, 1.5% m/v sodium polyphosphate, 
adjusted to pH 2.0, and 2 M formaldehyde; Set I reaction conditions from Figure 
4.3). 
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 Dopamine was most concentrated in the right hemisphere of nucleus 
accumbens consistent with findings by Inoue and co-workers [44], and 
norepinephrine was most concentrated in the right hemisphere of the hippocampus, 
as shown by Ahmad and co-workers [11]. The neurotransmitter levels quantified in 
the two rats were identical or similar in each of the brain regions with the exception 
of the right hippocampus and right nucleus accumbens, which showed a bigger 
variation between the samples (but within the expected range [11, 44]). For further 
application of the developed method an increase in the sample set to seven or eight 
rats and comparison of the mean concentration values would take into account the 
variance between animals across the brain regions of interest [11, 44]. An 
examination of the brain homogenates using HPLC/MS indicated the absence of 
components co-eluting with norepinephrine and dopamine, confirming that this 
1D-HPLC procedure provided sufficient resolution of the analytes in these samples.  
  Development of a separation for neurotransmitter metabolites in 
urine 
 Following the development of a successful method for analysing the rat 
brain samples, the focus was shifted to the determination of neurotransmitter 
metabolites in urine. Urine is a more favourable sample than the brain as it can be 
non-invasively acquired for routine analysis. Furthermore, the levels of specific 
metabolites in urine can be an accurate indication of the parent neurotransmitter 
levels in the body [23-25]. Urine contains sufficient levels of the metabolites for 
analysis [195] and the diet and related factors which impact their concentrations 
can be controlled for accurate analysis [26-28]. A urine sample was collected, 
diluted, filtered and separated using the method developed for the brain samples.  
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Table 4.2: Norepinephrine and dopamine content in ng/g tissue (and nmol/g in parentheses) in left and right hemispheres of three key 
rat brain regions, the hippocampus, nucleus accumbens and pre-frontal cortex. Results are expressed in ng/g and nmol/g for direct 
comparison to previous studies [18, 44]. Results from two individual rats shown.  
Neurotransmitter  Left 
Hippocampus  
Right 
Hippocampus 
Left 
Nucleus 
Accumbens 
Right 
Nucleus 
Accumbens 
Left 
Prefrontal 
Cortex 
Right 
Prefrontal 
Cortex 
Norepinephrine (Sample 1) 0.014     
(0.083) 
0.027    
(0.16) 
0.014 
(0.083) 
0.021  
(0.12) 
0.077 
(0.46) 
0.006 
(0.035) 
Norepinephrine (Sample 2) 0.012    
(0.071) 
0.012    
(0.071) 
0.023  
(0.14) 
0.021  
(0.12) 
0.064 
(0.38) 
0.005 
(0.030) 
Dopamine (Sample 1) 0.019    
(0.12) 
0.012    
(0.078) 
0.024  
(0.16) 
0.025  
(0.16) 
0.007 
(0.046) 
0.009 
(0.059) 
Dopamine (Sample 2) 0.024 
(0.16) 
0.025    
(0.16) 
0.021  
(0.14) 
0.049  
(0.32) 
0.012 
(0.078) - 
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Figure 4.5: Chromatogram showing separation of a human urine sample (black) 
and the same sample spiked (blue) with standards of the neurotransmitters 
norepinephrine (NE), dopamine (DA) and serotonin (5-HT); and the 
neurotransmitter metabolites: normetanephrine (NM), vanilmandelic acid (VMA), 
3,4-dihydroxyphenylacetic acid (DOPAC), 5-hydroxyindole-3-acetic acid (5-
HIAA) and homovanillic acid (HVA).  
The peak for each standard is labelled using the specified abbreviation. 
 
 The sample was also spiked with standards and the chromatograms overlaid 
in Figure 4.5 to confirm the retention of the key neurotransmitter and metabolite 
analytes.  
 As for the parent neurotransmitters, each metabolite was well retained on 
the Synergi Hydro-RP column with retention times of 12.2 min, 18.8 min, 26.3 min, 
29.1 min and 32.0 min for normetanephrine, vanilmandelic acid, 
3,4- dihydroxphenylacetic acid, 5-hydroxyindole-3-acetic acid and homovanillic 
acid respectively. 
NE 
NM 
DA 
VMA 
5-HT 
DOPAC 
5-HIAA 
HVA 
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Figure 4.6: Chemiluminescence intensity using different permanganate reagent conditions for the neurotransmitter metabolites, from 
left to right: VMA (green), MHPG (orange), DOPAC (purple), 5-HIAA (blue) and HVA (black), at 1 × 10-5 M. Note the intensity axis 
has been split to optimise comparison of the lower range values. Reagent conditions are as follows:  
Reagents A-B: 1 mM KMnO4, 1% (m/v) sodium polyphosphate, pH 2.5, using (A) no enhancer, or (B) 2 M formaldehyde.  
Reagents C-E: 1.9 mM KMnO4, 1% (m/v) sodium polyphosphate, using (C) pH 2.5, 0.6 mM Na2S2O3, (D) pH 2.5, 1 mM Na2S2O3, 
(E) pH 2.0, 1 mM Na2S2O3.   
Reagents F-G:  1 mM KMnO4, 1.5% (m/v) sodium polyphosphate, using (F) pH 2.5, (G) pH 2.0.  
Reagents H-J: 1.9 mM KMnO4, 1.5% (m/v) sodium polyphosphate using (H) pH 2.5, (I) pH 2.0, (J) pH 2.5, 2 M formaldehyde.   
Reagents K-N: 0.75 mM KMnO4, using (K) 1% (m/v) sodium polyphosphate, pH 2.5 (L) 1% (m/v) sodium polyphosphate, pH 2.5, 2 
M formaldehyde, (M) 1% (m/v) sodium polyphosphate, pH 2.0, 2 M formaldehyde, (N) 1.5% (m/v) sodium polyphosphate, pH 2.5 
and 2 M formaldehyde. 
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To ensure maximum sensitivity a reagent optimisation was also carried out for the 
metabolites vanilmandelic acid, 4-hydroxy-3-methoxyphenyl glycol, 5-
hydroxyindoleacetic acid, 3,4-dihydroxyphenylacetic acid and homovanillic acid. 
As for the parent neurotransmitters, of the wide range of conditions compared 
inFigure 4.6, the presence of formaldehyde had the biggest influence on emission 
intensity.  
 Using the conditions that gave the greatest overall emission intensities (Set 
L in Figure 4.6: 0.75 mM KMnO4, 1% m/v sodium polyphosphate, adjusted to pH 
2.5, and 2 M formaldehyde), limits of detection for the metabolites were established 
and are summarised in Table 4. 
 A fresh urine sample was then acidified, diluted 10-fold and then separated 
using the 1D-HPLC system as shown in Figure 4.7 with the optimised 
permanganate reagent conditions employed for detection. 
 
Table 4.3: Limits of detection (M) for the neurotransmitter metabolites 
vanilmandelic acid (VMA), 4-hydroxy-3-methoxyphenyl glycol (MHPG), 5-
hydroxyindole-3-acetic acid (5-HIAA), 3,4-dihydroxyindole-3-acetic acid 
(DOPAC) and homovanillic acid (HVA) using HPLC with acidic potassium 
permanganate chemiluminescence (S/N = 3). Reagent conditions: 0.75 mM 
KMnO4, 1% m/v sodium polyphosphate adjusted to pH 2.5, and 2 M formaldehyde 
(Set L in Figure 4.6).  
Neurotransmitter VMA MHPG 5-HIAA DOPAC HVA 
Limit of detection 
(M) 2.5 × 10
-7 1 × 10-7 2.5 × 10-8 5 × 10-8 1 × 10-7 
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Figure 4.7: Chromatogram showing separation of the human urine sample (diluted 
10-fold in deionised water) with normetanephrine (NM), vanilmandelic acid 
(VMA), 3,4-dihydroxyphenylacetic acid (DOPAC), 5-hydroxyindole-3-acetic acid 
(5-HIAA) and homovanillic acid (HVA) peaks identified, using permanganate 
chemiluminescence detection (0.75 mM KMnO4, 1% m/v sodium polyphosphate, 
adjusted to pH 2.5, and 2 M formaldehyde; as per Set L in Figure 4.6).  
 
  Analysis of urine using 2D-HPLC, method 1: sample 
characterisation 
 The complexity of the separation and co-elution of many components in 
 Figure 4.7 indicates that urine approaches the upper peak capacity limit for the 
one-dimensional method. The required gain in peak capacity is not possible using 
a single chromatographic dimension [2], therefore the focus was shifted to 
2D- HPLC with potassium permanganate chemiluminescence. Two methods were 
developed, the first for entire sample characterisation and the second for analysis 
of the target neurotransmitter metabolites only; whilst both methods have their 
specific role, the distinguishing factor between them is the run time. For the 
characterisation method the run time was five hours compared to one hour for the 
NM 
VMA 
DOPAC 
5-HIAA 
HVA 
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targeted analysis, which is much more comparable to the 35 minute 1D-HPLC 
separation. 
 The 2D-HPLC separations were developed by undertaking a selectivity 
study to find a suitable pair of separation environments to provide a good use of 
separation space based on their combined retention mechanisms. Retention factors 
for each of the standards were calculated from the elution time data, to assess the 
correlation and spreading angles on each stationary phase. An amino × cyano 
column combination showed the greatest spreading angle and lowest correlation of 
the compared combinations. However this combination was judged as not suitable, 
due to the elution of normetanephrine in the void of the first dimension. Therefore 
the Synergi Hydro-RP × cyano combination was selected as retention and 
separation of each analyte occurred over the two dimensions (Figure 4.8).  
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(a) 
 
 
(b) 
 
Figure 4.8: Individual one dimensional chromatograms for the longer sample 
characterisation 2D-HPLC method. The chromatograms show the metabolites 
normetanephrine (NM), 3,4-dihydroxyphenylacetic acid (DOPAC), vanilmandelic 
acid (VMA), 5-hydroxyindole-3-acetic acid (5-HIAA) and homovanillic acid 
(HVA); using the: (a) Synergi Hydro-RP first dimension; and (b) Cyano second 
dimension.  
NM 
VMA 
DOPAC 
5-HIAA 
HVA 
NM 
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 The method of each column was optimised for the off-line two-dimensional 
analysis so that all fractions collected in the first dimension in a 5.5 minute window 
between 4 and 9.5 minutes and the second dimension was complete in under five 
minutes. The chemiluminescence surface plot of the separation is shown (Figure 
4.9) and custom peak picking software was used to identify a total of 55 separated 
compounds that elicit chemiluminescence with acidic potassium permanganate.  
 
 
Figure 4.9: Two-dimensional chemiluminescence surface plot of urine sample 
using permanganate chemiluminescence. Each peak is identified using white dots, 
with the metabolites vanilmandelic acid (VMA), 5-hydroxyindole-3-acetic acid (5-
HIAA) and 3,4-dihydroxyphenylacetic acid (DOPAC) identified using standards. 
Peak intensity variations are represented by a hot to cold colour gradient. 
 
VMA 
5-HIAA 
DOPAC 
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 Peaks corresponding to the key neurotransmitter metabolites were 
confirmed by spiking the urine sample with standards. Vanilmandelic acid, 
3,4- dihydroxyphenylacetic acid and 5-hydroxyindole-3-acetic acid were identified 
in the sample and resolved from co-eluting compounds. The inability to determine 
homovanillic acid and normetanephrine can be attributed to the loss in sensitivity 
experienced in 2D-HPLC from the transfer of eluent fraction from the first 
dimension into the second dimension. 
  Analysis of urine using 2D-HPLC, method 2: neurotransmitter 
metabolites 
 Despite the power of the above 2D-HPLC in separating over 55 components 
of the urine, a 5 hour method is of limited practical value for routine analysis and 
screening of real samples. Therefore an alternative method was developed and 
targeted specifically at the neurotransmitter metabolites, with a run time more 
comparable to 1D-HPLC. Sufficient retention and resolution of each metabolite 
was obtained using a cyano phase for the first dimension and a C18 for the second, 
with both columns comprised of superficially porous particles. In practice the run 
time was considerably shortened by only heart cutting the eluent fractions of 
interest from first dimension, enabling the superior peak resolution of 2D-HPLC 
with a separation time comparable to 1D-HPLC. 
 This method was also more sensitive toward the neurotransmitter 
metabolites, enabling the identification of vanilmandelic acid, 
3,4- dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindole-3-acetic 
acid in the human urine sample. Figure 4.10 compares the separation of the standard 
mixture and urine using the targeted 2D-HPLC method.   
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(a) 
 
(b) 
 
Figure 4.10: Two-dimensional (heart-cutting) HPLC-chemiluminescence surface 
plots for: (a) a mixture of five analyte standards; and (b) a diluted human urine 
sample. Black circles show the position of the target analyte peaks. All detected 
peaks are coloured red.  
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 To quantify these analytes using this two dimensional separation, 
calibrations were prepared using a series of standard mixtures (R2 = 0.9962, 0.9997, 
0.9955 and 0.9936). After accounting for the sample dilution, their concentrations 
in the urine were found to be 5.5 × 10-5 M for vanilmandelic acid, 1.9 × 10-6 M for 
3,4-dihydroxyphenylacetic acid, 1.4 × 10-5 M for homovanillic acid and 9.2 × 
10- 6 M for 5-hydroxyindole-3-acetic acid. Whilst these values are reasonable 
considering normal reference values [3], it is important to consider day to day 
variability, diet and lifestyle factors when making comparisons between urine 
samples using any analytical methodology. 
 Following the successful determination of four neurotransmitter 
metabolites in the sample, the developed method could be applied to the widespread 
screening of human urine as part of the approach to diagnosis and monitoring of 
diseases. Whilst only four metabolites were identified in this sample, the method 
could be readily adapted to the simultaneous determination of a larger number of 
target compounds in order to suit the desired application. The ability to determine 
the metabolites within normal reference values and improved separation of sample 
components with similar analysis times to one-dimensional techniques are key 
features of the developed method that make it an attractive alternative for the 
routine analysis and screening of urine samples.  
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4. Conclusions 
 The chemiluminescence reaction of neurotransmitters with acidic 
potassium permanganate was successfully coupled to 1D-HPLC for the 
determination of norepinephrine and dopamine in key brain regions of rats, with 
levels consistent with previous reports using alternative detection methods. This 
procedure was then adapted for the determination of the neurotransmitter 
metabolites normetanephrine, vanilmandelic acid, 3,4-dihydroxyphenylacetic acid, 
5-hydroxy-3-indoleacetic acid and homovanillic acid in human urine, which 
showed that the peak capacity of the separation was exceeded when analysing this 
highly complex sample.  
 A two-dimensional separation was subsequently developed and the superior 
peak capacity harnessed for the resolution of key neurotransmitter metabolites from 
unidentified co-eluting compounds found in urine. A five hour two dimensional 
separation provided separation of the complete urine sample with the identification 
of 55 peaks including three of the metabolites. Whilst this method provided good 
sample separation, the analysis time is too long for application to routine analysis. 
Therefore a second more targeted 2D-HPLC method was developed with a run time 
of an hour, comparable to the 1D-HPLC separation. Four of the analytes were 
identified using the targeted method which is more useful for extension to routine 
diagnosis and monitoring of disease via the screening of neurotransmitter 
metabolites in urine. 
 
The work presented in this chapter is published as: B. Holland, X. Conlan, P. 
Stevenson, S. Tye, A. Reker, N. Barnett, J. Adcock, P. Francis, ‘Determination of 
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neurotransmitters and their metabolites using one- and two-dimensional liquid 
chromatography with acidic potassium permanganate chemiluminescence 
detection’, Analytical and Bioanalytical Chemistry, 406 (2014) 5669-5676. 
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Chapter Five 
 
Novel strategies for overcoming performance limiting solvent 
mismatch in two- dimensional reversed phase high performance 
liquid chromatography 
 
1. Introduction  
Dissolving a polar salt or a compound into the first dimension eluent 
fraction may assist in overcoming solvent mismatch by accelerating the transfer 
rate for the analyte from a strong solvent plug into the weaker mobile phase [126]. 
This can occur as the polar additive will be more soluble in the mobile phase which 
has a weaker solvent strength than the injection plug, as ‘like-dissolves-like’. 
Therefore it has been postulated that the polar additive will transfer more rapidly 
into the mobile phase, potentially promoting the transfer of sample compounds 
from the injection plug at the column head and reducing peak shouldering [121, 
200]. A suitable polar additive may also initiate on-column solute focussing, 
reducing the width of the injection band and consequently the chromatographic 
peaks [121]. A polar salt or compound, i.e. ammonium acetate or thiourea 
respectively, must be carefully selected to ensure its elution time is different to the 
sample components. The use of polar additives has not been attempted in 2D-HPLC 
applications as they would need to be manually introduced to the eluent fractions 
post collection or via a prepared solution that is merged with the first dimension 
solvent. Manually adding a compound to the fractions is labour intensive and 
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subject to reproducibility errors, whilst merging a solution with the eluent dilutes 
the collected fractions and reduces method sensitivity. 
A second strategy, mixing and co-injecting a polar solvent with the eluent 
fraction is effective for promoting analyte transfer onto the stationary phase [121, 
122, 126]. Reducing the polarity differences between the injection plug and mobile 
phase also lowers viscosity mismatch reducing additional performance issues such 
as viscous fingering [119, 120]. Layne and co-workers [122] used this strategy with 
a longer gradient time on the second dimension, which generated a significant 
improvement in chromatographic performance. However the method was too slow 
for online 2D-HPLC applications [126]. This chapter aims to implement mixing 
and co-injection of a polar solvent with the eluent using an additional HPLC pump, 
similar to the counter gradient method [52]. By using sample loops of sufficient 
volume, a method can be developed that is suitable for online 2D-HPLC with fast 
second dimension gradients. However, this method will face the same drawbacks 
as the counter gradient, including reduced sensitivity from sample dilution and 
experimental design issues when low solvent compositions are required [52].  
The third strategy which is investigated in this chapter, is temperature 
programmed HPLC separations coupled to a second dimension with a standard 
mobile phase gradient. Aqueous solvents are known to exhibit less polar 
characteristics when they are heated [201]. Therefore, if operated under isocratic 
conditions, temperature programming can provide the benefits of typical gradient 
chromatography in reducing run times and band broadening, whilst maintaining a 
constant mobile phase eluent [201]. Accordingly, the peak capacity of a 2D-HPLC 
separation can be maximised if temperature programming is used in the first 
dimension with a low organic solvent concentration, which allows use of a full 
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mobile phase gradient in the second. The full benefits of gradient elution are then 
realised in both dimensions without a deterioration in peak shape [202, 203]. 
Additionally, no modification of the eluent fraction will be required prior to 
injection in the second dimension, eliminating the need for additional pumps and 
tubing. Temperature programmed separations therefore offer a useful alternative 
for first dimension separations in 2D-HPLC, without the reduced sensitivity and 
difficulties associated with implementing counter and shift style gradients. Lower 
solvent viscosity and higher kinetics allow for shorter run times than under 
isothermal conditions [202, 204].  
The most effective of the solutions explored in this chapter will be utilised 
for development of an online comprehensive 2D-HPLC separation of selected 
standards with wide ranging polarities, a coffee extract and a urine sample. The 
benefits and capacity of the method will be judged by comparison to previous 
reports of the 2D-HPLC separation of coffee and urine samples [51-53]. 
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2. Experimental 
  Chemicals and reagents 
Analytical grade methanol was obtained from Chem Supply (Gilman, SA, 
Australia) and HPLC grade from Ajax (Tarren Point, NSW, Australia). Reagent 
grade toluene, ethyl-, propyl-, butyl- and n-pentyl- benzene, bisphenol A, caffeine, 
phenol, anthracene, anisole and resorcinol were purchased from Sigma-Aldrich 
(Castle Hill, NSW, Australia). HPLC grade acetonitrile was also purchased from 
Sigma-Aldrich. Thiourea was supplied by BDH chemicals (Frenchs Forest, NSW, 
Australia). Dimethyl phthalate was obtained from UniLab (Thermo Fisher, 
Scoresby, Victoria, Australia). Dopamine hydrochloride and homovanillic acid 
were sourced from Alfa Aesar (Gymea, NSW, Australia), and morphine from 
GlaxoSmithKline (Port Fairy, Victoria, Australia). Deionised water filtered 
through a 0.45 μm filter (Sigma-Aldrich) before use in the mobile phase.  
 
  Sample preparation 
Fresh coffee samples were obtained daily via extraction of 5 g Ristretto brand 
Nespresso coffee beans (Nespresso, North Sydney, NSW, Australia) with 30 mL 
hot water, using a Saeco Royal Pro model coffee machine (Philips, Macquarie 
Park, Australia). The extract was filtered with a 0.45 μm syringe filter and prepared 
with a concentration of 5% methanol prior to analysis.  
Fresh urine samples were collected daily and preserved by adding a 7.5 M 
hydrochloric acid solution (50 μL per 1 mL of urine) and stored at 4 °C until 
required. Immediately prior to analysis the preserved sample was diluted 10-fold 
with deionised water and filtered with a 0.45 μm syringe filter. 
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Standards and solvents for the polar additives work were prepared as 
specified in the results and discussion section of this chapter. Morphine (1 × 
10- 3 M) was prepared by sonication in acidified deionised water to aid dissolution 
and diluted to 1 × 10-5 M for analysis. Bisphenol A, phenol, anisole, caffeine, 
propylbenzene, butylbenzene and n-pentylbenzene (10 mg L-1) were prepared in 
acetonitrile and diluted to 1 × 10-5 M at the relevant initial acetonitrile composition 
of the first dimension for analysis. The remaining analytes were prepared in 
deionised water at 10 mg L-1 and diluted to 1 × 10-5 M in acetonitrile matching the 
starting composition of the method.  
 
  HPLC 
An Agilent 1260 chromatograph consisting of a binary capillary pump with 
solvent degasser, a 1290 Infinity binary pump with solvent degasser, autosampler, 
1290 Infinity thermostatted column compartment containing an in-built 8-port, 
2- position switching valve and a diode array detector module that monitored 
absorbance at 254 nm (Agilent Technologies, Mulgrave, Victoria, Australia) was 
used for all analyses. Agilent Chemstation software was used for system control 
and data acquisition. To examine the effectiveness of polar solutes and solvents an 
Agilent Poroshell EC-C18 was used (100 × 4.6 mm column dimensions, 2.7 μm 
particle diameter). A 20 μL injection was made into an acetonitrile mobile phase 
flowing at 1 mL min-1. A linear acetonitrile gradient from 5% to 95% over 11 min 
was used, with a run time of 13 min and 10 min re-equilibration between injections.  
An online comprehensive two-dimensional separation with a temperature 
programmed first dimension was developed and individually adapted for the 
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standards and samples. At the separation interface sequential 1 min fractions 
(standards) or 2 min fractions (coffee and urine) were collected using the switching 
valve and two 40 μL sample loops, in a configuration where one loop fills whilst 
the other was emptying into the second dimension. A Gemini C18 column (50 × 
1 mm column dimensions, 3 μm particle diameter, 110 Å pore diameter, 
Phenomenex, Lane Cove, NSW, Australia) was used in the first dimension. A 
volume of 40 μL was injected by the autosampler into a mobile phase flowing at 
20 μL min-1, containing a methanol concentration of 5% for the sample and 40% 
for standards.  
Temperature programming was performed in the first dimension where the 
column temperature was increased from 15 °C to 91.8 °C at a rate of 3.2 °C min-1 
immediately upon injection, then held isothermally at 91.8 °C until the end of the 
separation. Second dimension separations were carried out using a Kinetex Phenyl-
Hexyl column (100 × 4.6 mm column dimensions, 2.6 μm particle diameter, 110 Å 
pore diameter, Phenomenex) isothermally at 60 °C with a flow rate of 4.5 mL min-
1 (standards) or 4.0 mL min-1 (coffee and urine). For the standards a methanol 
gradient was used, increasing linearly from 67% to 100% over 0.2 min before being 
held for a further 0.2 min at 100%, with a 0.6 min re-equilibration time. A linear 
gradient from 5% to 100% methanol was used for the coffee and urine, carried out 
over 1.4 min with a 0.6 min re-equilibration time. To allow even cooling of the first 
dimension column, a thermal re-equilibration time of 45 min was used between 
injections.  
Prior to data analysis, baselines were corrected using a parameterised least 
squares smoothing filter [197]. Two-dimensional chromatographic data recorded 
by ChemStation was then imported to Wolfram Mathematica 10 (distributed by 
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Hearn Scientific Software, Melbourne, Victoria, Australia) and converted to two-
dimensional surface plots, which distinguish peaks of different intensities using a 
hot to cold colour gradient [198].  
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3. Results and Discussion 
  Using polar solutes to overcome solvent mismatch 
To demonstrate solvent mismatch in 2D-HPLC standards prepared in 40% 
acetonitrile were injected onto a column equilibrated at 5% acetonitrile. The 
resulting chromatogram shown in Figure 5.1 illustrates how Gaussian peak shapes 
were observed in those retained quite strongly (> 5.5 min), while caffeine which 
eluted earlier at 4 min demonstrated shouldering.  
 
 
Figure 5.1: Separation of caffeine, phenol, dimethyl phthalate, propyl benzene and 
anthracene prepared in 40% acetonitrile. A gradient of 5%- 95% acetonitrile over 
13 min was used. Distortion of peak shape is clear only in the shouldering caffeine 
(retention time of 4 min). 
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Poorly retained peaks, such as caffeine, are most affected by solvent 
mismatch as their interactions with the stationary phase are weaker. Thus when 
introduced into a strong solvent, caffeine is slower to migrate from the injection 
band and is dragged further along the column before completely migrating from the 
solvent plug [121]. To assess whether a polar compound would change the injection 
environment significantly enough to enhance the migration from the solvent plug, 
thiourea and caffeine were mixed in 40% acetonitrile and introduced under the 
same conditions as Figure 5.1. Thiourea is unretained and may move rapidly from 
the injection band off the column, promoting the transfer of caffeine and improving 
the peak shape, without co-eluting. However as shown in Figure 5.2, thiourea is 
ineffective at improving the caffeine peak shape in this concentration range.  
 
 
Figure 5.2: Chromatogram depicting the peak shape profile of caffeine (retention 
time 4.0 min) with the addition of thiourea (retention time 1.05 min). Caffeine and 
thiourea were prepared in 40% acetonitrile. A gradient of 5%- 95% acetonitrile over 
13 min was used for the separation. 
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As thiourea provided no benefit to aiding the transfer of caffeine onto the 
stationary phase inlet to improve peak shape ammonium acetate was mixed in the 
same manner and trialled. Figure 5.3 shows a comparison of three salt 
concentrations; however as for thiourea there was no improvement in peak shape. 
 
 
Figure 5.3: Chromatogram depicting the peak shape profile of caffeine (retention 
time 4.0 min) with the addition of ammonium acetate. Caffeine was prepared in 
40% acetonitrile and injected into a mobile phase of 5%. 
 
  Mixing injection plugs with polar solvents to overcome solvent 
mismatch 
Caffeine prepared in 40% acetonitrile was subsequently diluted 1:1 with a 
number of solvents, to simulate post first dimension mixing in 2D-HPLC. Each 
solvent shown in Figure 5.3 improved peak shape from Figure 5.1, but still showed 
signs of degradation observed as fronting and shouldering. Water gave the best 
improvement, as it was the most polar of the solvents trialled and the strength 
difference is effectively halved when it is mixed in a 1:1 ratio with the caffeine. An 
injection plug of dimethyl sulfoxide was also compared, where 20 μL was drawn 
into the needle, followed by 20 μL of caffeine and finally 20 μL of solvent (see 
Figure 5.4). The injection plug however was less effective than mixing caffeine 
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with the polar solvent, as significant peak shouldering was still observed. As a 
result, this work using polar solvents was not further pursued. 
 
 
Figure 5.4: Effects of mixing the caffeine prepared in 40% acetonitrile in a 1:1 
ratio with a selected solvent prior to injection. Five conditions were compared: (a) 
tetrahydrofuran, blue; (b) acetone, red; (c) ethanol, green; (d) dimethyl sulfoxide, 
orange; and (e) 20 μL dimethyl sulfoxide drawn before and after the standard 
solution, purple. 
 
  Operational parameters for temperature programmed HPLC 
A shift in the focus for overcoming solvent mismatch in 2D-HPLC was 
developed using a temperature programmed separation in the first dimension with 
an isocratic mobile phase. More attention is required for method development, but 
temperature programming is less complex to implement at the separation interface 
than using polar solutes or solvents; the first dimension fractions are simply 
collected using sample loops and injected into the second using a switching valve. 
A narrow bore Gemini C18 column was selected for the first dimension, as the 
internal diameter of 1 mm allows for a more uniform heating than typical analytical 
scale formats [202]. Although a micro bore column with an internal diameter of 
0.5 mm would allow for a more rapid transfer of thermal energy, those available 
(a) (b) (c) 
(d) (e) 
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were only rated to operate up to 60 °C. The column chosen was suitable for use at 
temperatures up to 90 °C according to the manufacturer. This extended range 
beyond 60 °C is a significant factor, considering that temperature has a smaller 
relative influence on manipulating retention than changing the mobile phase 
composition [202]. Thus the higher temperature limit of the Gemini C18 column 
provided an overall advantage of shorter run times for the strongly retained analytes 
compared to the micro bore alternatives, despite the slower rate of thermal energy 
transfer. 
The instrument design included a thermostat with a mobile phase preheater 
prior to the column which is considered beneficial in reducing axial temperature 
gradients, and a capillary HPLC pump to ensure steady delivery of the required low 
flow rate [205]. The thermal equilibration time of the column was measured by 
injecting thiourea, phenol and anisole after the thermostat had returned to 15 °C 
(from 90 °C) and a specified period had lapsed (see Figure 5.5).  
A 17.5 minute thermal re-equilibration was required to obtain reproducible 
retention times for phenol and anisole, which is somewhat longer when compared 
to a mobile phase which required 12 min under these conditions. 
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Figure 5.5: Influence of thermal re-equilibration time on the retention behaviour 
of three analytes, anisole, phenol and thiourea. Re-equilibration time was measured 
as the time allowed for the system to idle at initial conditions after the thermostat 
had completely cooled. 
 
  Optimising the temperature gradient rate 
The temperature limits for the method were established by examining the 
heating, cooling and re-equilibration rates for the thermostat and column system. 
A gradient starting temperature of 15 °C and maximum of 90 °C was selected based 
on manufacturer specifications. The column thermostat was capable of heating 
over the temperature range in 13 min at an average rate of 5.8 °C min-1, and cooled 
over 20 min at 3.8 °C min-1. The combined cooling and thermal equilibration times 
required an interval of almost 40 min between injections, due partly to the slow 
process of energy transfer from the heating block to the column via the air in the 
oven- 3.8 °C min-1, as measured by the instrument thermostat. Although beyond 
the scope of this thesis, integrating a cooling system or using a temperature source 
in direct contact with the column could reduce the re-equilibration time and render 
the method more suitable for high throughput routine analysis [205]. Conversely, 
the controlled column heating gives the method greater power to separate closely 
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eluting compounds by gradually manipulating their retention factors, whilst 
maintaining acceptable retention times for more strongly retained species.  
Linear temperature gradient rates from 2 to 8 °C min-1 over the operating 
range were studied for their effect on the retention and separation of selected polar 
and non-polar standards. This range of temperature gradient rates was selected as 
they fell within the operational capabilities of the thermostat. For simplicity, non-
linear thermal gradients were excluded from the study. A mobile phase 
composition of 40% methanol was selected to reduce the retention times of the 
non-polar analytes while maintaining an adequate resolution of the earlier eluting 
compounds, which was lost at higher concentrations.  
The retention of a series of standards when separated under various 
isothermal and gradient temperature profiles are presented in Table 5. When 
comparing the retention data at 50 °C (isothermal) with a programmed increase of 
5 °C min-1, the temperature gradient also maintained (and in some cases improved) 
the separation of these standards. The selectivity factor (α = ௞మ௞భ) of adjacent peaks 
suggests that a lower initial temperature allowed for better resolution of poorly 
retained components (see Figure 5.6), compared to higher temperatures where the 
relative retention was much lower, while still achieving baseline separation. 
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Figure 5.6: Separation of thiourea and caffeine under isothermal conditions of 
15 °C and 85 °C. Resolution of these analytes is temperature dependent, occurring 
under the lower thermal conditions. 
 
The significance of temperature programming was further highlighted 
(Table 5.1) by the reduction in elution times of butyl- and n-pentyl benzene from 
three hours under isothermal conditions of 50 °C, to less than an hour at a gradient 
of 5 °C min-1. The utilisation of temperature to influence selectivity is highlighted 
by the changing retention order of both L-alanine and bisphenol A. From the data 
in Table 5.1, an 8 °C min-1 thermal gradient was selected for the first dimension 
separation to balance resolution and retention factors, and maintain a short analysis 
time. 
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Table 5.1: Comparison of retention factor (k) and retention time (tR) over a selection of isothermal and temperature programmed trials, 
using an isocratic 40% methanol mobile phase. *Data not collected due to excessive analysis times. 
Analyte 
15 °C isothermal 50 °C isothermal 85 °C isothermal 2 °C min-1 5 °C min-1 8 °C min-1 
tR (min) k tR (min) k tR (min) k tR (min) k tR (min) k tR (min) k 
dopamine 1.19 0.1 1.10 0.1 1.04 0.0 1.15 0.0 1.15 0.1 1.21 0.1 
morphine 1.19 0.1 1.10 0.1 1.04 0.0 1.15 0.0 1.15 0.0 1.19 0.1 
thiourea 1.28 0.2 1.20 0.2 1.17 0.1 1.29 0.2 1.26 0.1 1.29 0.2 
resorcinol 1.70 0.5 1.41 0.4 1.27 0.3 1.64 0.5 1.63 0.5 1.69 0.5 
caffeine 1.79 0.6 1.49 0.5 1.35 0.3 1.75 0.6 1.76 0.6 1.95 0.8 
L-alanine 1.97 0.8 1.80 0.8 1.62 0.6 1.94 0.8 1.89 0.7 2.05 0.9 
homovanillic 
acid 2.16 1.0 1.55 0.5 1.35 0.3 2.05 0.9 2.08 0.9 2.19 1.0 
phenol 2.59 1.4 1.84 0.8 1.53 0.5 2.45 1.2 2.44 1.2 2.58 1.3 
bisphenol A 5.56 4.1 6.87 5.7 3.02 2.0 1.94 0.8 -  -   - 
anisole 6.91 5.3 3.79 2.7 2.60 1.6 6.31 4.7 6.19 4.6 2.56 1.2 
toluene 14.26 10.9 7.13 6.0 4.26 2.6 * * 11.37 9.3 10.95 8.5 
ethyl benzene 30.92 24.8 13.32 12.1 6.96 4.8 * * 18.10 15.5 17.26 14.0 
n-propyl 
benzene 79.2 65.0 28.5 26.9 12.8 9.7 * * 27.0 23.6 26.56 22.1 
butyl 
benzene 208.2 172.5 63.2 61.0 24.5 19.4 * * 39.0 34.5 39.9 33.7 
pentyl 
benzene > 350  * > 350 136 48.0 39.0 * * 58.5 52.2 62.2 53.1 
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  Developing a two-dimensional method for separation of the standard 
mixture 
 In the online comprehensive mode of 2D-HPLC, the sampling frequency is 
limited by the second dimension, which must complete its separation and re-
equilibration cycle in the time taken for the first to fill the sample loop. A fast 
second dimension separation was required with a mobile phase gradient 
commencing with an ideal minimum of 40% methanol to avoid potential mismatch 
issues with the first. The phenyl-hexyl column was used to develop a fast second 
dimension cycle with an aggregate time of 1 min, comprising of 0.4 min separation 
and 0.6 min re-equilibration. The final second dimension method used a 68% to 
100% methanol gradient, in order for the separation and re-equilibration cycle to 
be completed in 1 min. The chromatogram (Figure 5.7a) shows the separation of 
the standards on the second dimension. 
The first dimension flow rate was adjusted to allow the desired sampling 
rate of 3 cuts per peak, at a frequency of 1 fraction per minute as dictated by the 
second dimension. This was achieved by reducing the flow rate from 50 to 20 μL 
min-1 and scaling the temperature gradient down from 8 to 3.2 °C min-1. The 
resulting first dimension chromatogram for the standards is shown in Figure 5.7b. 
The separation dimensions were coupled via a switching valve and sample loops to 
create a comprehensive on-line 2D-HPLC analysis of the 14 standards. The surface 
plot of the 2D-HPLC separation is illustrated in Figure 5.8, showing resolution of 
13 standards which co-eluted in the one-dimensional space.  
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(a)  
 
 
(b)  
 
Figure 5.7: (a) Second dimension separation of selected polar and non-polar 
analytes using the Kinetex column and a 0.1 min mobile phase gradient from 67 to 
100% methanol, at 60 °C. 
(b) First dimension separation of the selected polar and non- polar analytes using a 
3.2 °C min-1 gradient from 15 to 91.8 °C, with a mobile phase composition of 40% 
methanol.  
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Figure 5.8: Online comprehensive two-dimensional surface plot of the standard 
mix separation. White dots represent peaks picked using algorithms, undertaken in 
35 min (1 fraction transferred between dimensions per minute) [198]. Variations in 
peak intensity are represented by a hot to cold colour gradient. 
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Although 120 min was required to elute all standards on the first dimension 
(Figure 5.7a) no peaks were observed after 33 min in the 2D-HPLC separation due 
to a loss in sensitivity. The degraded sensitivity is a result of dilution during the 
transfer between dimensions and the limited injection volumes required to avoid 
overloading of the narrow bore column. The resulting 2D-HPLC method was able 
to separate the standards which co-eluted in the first dimension. Significantly, 
symmetric peak shapes were observed for all fractions owing to the consistent 
eluent concentrations injected into second dimension. Whilst correlation between 
the dimensions could be reduced with a more rigorous approach to selecting the 
stationary phases, at least three hours of analysis time was saved by incorporating 
a temperature gradient. 
 
 Adaption of the two- dimensional method for a real sample separation 
A separation of coffee extract and human urine was designed to assess the 
performance of a temperature gradient on chemically complex real samples. Coffee 
is an important source of natural antioxidants consumed worldwide [32-35], and 
the beans are known to have an extremely complex chemical composition [51]. 
Furthermore, as a number of 2D-HPLC separations have recently been developed 
it is possible to directly compare the performance of this method [51-53]. Human 
urine was selected as it is a useful sample for monitoring the levels of 
neurotransmitter metabolites in the diagnosis and monitoring of disease [29, 31, 
206], and the method can be compared to other separations developed in this thesis 
[53, 207].  
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Firstly, to adapt the method from that used for the standards, the methanol 
composition of the first dimension mobile phase was reduced to 5% to facilitate 
better retention and separation of the polar components within the coffee and urine 
samples. The temperature gradient rate was unaltered at 3.2 °C min-1, with a 20 μL 
min-1 flow rate. The chromatogram from the first dimension separation of coffee is 
shown in Figure 5.9a.  
The second dimension was also modified to improve the method sensitivity 
for the coffee by doubling the fraction volumes collected from the first (Figure 
5.9b). Although this reduced the sampling rate (to 1.5 fractions per peak), greater 
separation in the second dimension was achieved by lowering the flow and using a 
larger difference between the initial and final gradient compositions. The resulting 
surface plot of the 2D-HPLC coffee extract separation is illustrated in Figure 5.10, 
where 34 peaks were detected using peak picking algorithms with a 35 min analysis 
time. 
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(a)  
 
 
(b)  
 
Figure 5.9: (a) First dimension separation of the coffee sample using a 3.2 °C min-
1 gradient from 15 to 91.8 °C, with a mobile phase composition of 5% methanol. 
(b) Second dimension separation of coffee extract using the Kinetex column and a 
1.4 min mobile phase gradient from 5 to 100% methanol, at temperature of 60 °C. 
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Figure 5.10: Two-dimensional separation of the coffee extract, where white dots 
represent peaks picked using algorithms, completed in 35 min [198]. Variations in 
peak intensity are represented by a hot to cold colour gradient. 
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The conditional peak capacities for the first and second dimensions were 
19.3 and 5.65 respectively, yielding an overall theoretical value of 109.3. 
Orthogonality and spreading angle were calculated and compared against previous 
methods to measure the effectiveness of this separation. Figure 5.11 illustrates the 
division of the separation space into 34 bins, to calculate the orthogonality of 35% 
[102, 107, 198].  
 
 
Figure 5.11: Calculating orthogonality of the separation using the bins method. 
The separation was divided into 34 bins, as peak picking algorithms identified 34 
peaks, shown by blue dots. The shaded grey area shows the bins containing peaks. 
The orthogonality was then calculated by totalling the area of all normalised bins 
containing peaks [102, 107, 198]. 
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 A spreading angle of 52° was then determined from Figure 5.12 following 
a geometric approach to factor analysis [102].  
 
Figure 5.12: Calculation of the spreading angle to determine effective separation 
space used for the coffee separation [102]. 
 
Both the orthogonality and spreading angles calculated for this separation 
compare favourably against those previously reported 2D-HPLC separations of 
coffee [51-53]. Bassanese and co-workers reported an orthogonality of 39% with a 
48 min separation [53]. Stevenson et al. incorporated a counter gradient in between 
dimensions and reported a 10% use of separation space and 70.5° spreading angle 
over a 5.25 hour analysis [52]. Mnatsakanyan et al. reported a spreading angle of 
56° with a run time of 21 hours [51]. Two-dimensional HPLC using a temperature 
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gradient in the first dimension provided a more favourable analysis time than those 
of the latter two studies [51, 52], even when considering the long re-equilibration 
between analyses. However, the use of a narrow bore HPLC column resulted in a 
lower sensitivity whereby fewer peaks were detected than other methods. This 
arose from the combined small injection volumes on the narrow bore column and 
transfer of fractions between separation dimensions.   
A human urine sample was then separated in 25 min using the 2D-HPLC 
method employed for the coffee extract. The two-dimensional surface plot in Figure 
5.14 shows the improved resolution in 2D-HPLC of co-eluting peaks from the 
individual chromatograms in Figure 5.13a-b. A total of 38 peaks were found in the 
urine sample using peak picking algorithms [198].  
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(a)   
 
(b)  
 
Figure 5.13: (a) First dimension separation of urine using a 3.2 °C min-1 gradient 
from 15 to 91.8 °C, with a mobile phase composition of 5% methanol. 
(b) Second dimension separation of urine using the Kinetex column and a 1.4 min 
mobile phase gradient from 5 to 100% methanol, at temperature of 60 °C. 
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Figure 5.14: Two-dimensional separation of the urine sample, where white dots 
represent peaks picked using algorithms, completed in 25 min [198]. Variations in 
peak intensity are represented by a hot to cold colour gradient. 
 
  
Chapter Five 
122 
 
The urine separation had a orthogonality of 38% calculated via the bins 
method in Figure 5.15, and a spreading angle of 70° shown in Figure 5.16 [53, 102, 
107]. 
 
 
Figure 5.15: Calculating orthogonality of the urine separation using the bins 
method. The chromatogram was divided into 38 bins, (38 peaks picked-blue dots). 
Orthogonality then calculated by totalling the area of all normalised bins (grey) 
containing peaks [102, 107, 198]. 
 
Chapter Five 
123 
 
 
Figure 5.16: Calculation of the spreading angle to determine effective separation 
space used for the urine separation [102]. 
 
 This resulting urine separation also compared favourably with a previously 
method which reported 2D-HPLC separation which had an orthogonality of 30% 
[53]. The run time of 25 min (65 min including thermal equilibration) was a 
significant improvement on the 10.5 hours of the aforementioned method [53]. The 
practical peak capacities for the first and second dimensions of this separation were 
14.7 and 5.1 respectively, yielding an overall theoretical value of 74.7.  
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4. Conclusions 
Adding polar solutes to a strong injection solvent did not provide a means 
to successfully overcome solvent mismatch when a weaker mobile phase was used. 
Significant shouldering of an earlier eluting was still observed when high 
concentrations of thiourea and ammonium acetate were added to the injection 
solvent. Mixing and co-injecting polar solvents with strong sample plugs reduced 
the degree of peak shouldering, but did not eliminate peak fronting. Conversely, 
temperature programming with an isocratic mobile phase in the first dimension 
removed the deleterious effects of solvent mismatch and improved sensitivity from 
other complex interfacing solutions in 2D-HPLC.  
An online comprehensive 2D-HPLC method, with a temperature 
programmed first dimension separation coupled to a mobile phase gradient in the 
second was successfully applied to analysis of a selection of standards, a coffee 
extract and a urine sample. The resulting method avoided solvent incompatibility 
at the separation interface, ensuring peaks in the second dimension retained a 
symmetrical profile, to the benefit of peak capacity and reduced retention times.  
However, the need for HPLC columns stable at high temperatures is 
limiting for many applications. The extended thermal re-equilibration times in the 
order of 40 min are also unfavourable for high throughput routine analysis, 
requiring further attention from the instrumental and column design viewpoint. The 
analysis time however was still more enticing than other methods described in the 
literature [51, 198]. A coffee extract and urine sample were successfully separated 
using the developed method, which maintained the separation performance 
observed in other separations. 
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The work presented in this chapter has been submitted for publication as: Brendan 
J. Holland, Xavier A. Conlan, Paul S. Francis, Neil W. Barnett and Paul G. 
Stevenson, ‘Using temperature programming to overcome performance limiting 
solvent mismatch in two-dimensional reversed phase high performance liquid 
chromatography’, Submitted August 2015 to Analytical Methods (RSC 
Publications). 
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Chapter Six 
 
In silico stationary phase selection and method development for 
two-dimensional high performance liquid chromatography  
 
1. Introduction 
The performance and resolving power of two-dimensional high 
performance liquid chromatography (2D-HPLC) is dependent on a number of 
parameters including mobile phase type, pH, flow rate, temperature and stationary 
phase selectivity [1, 208]. The multitude of factors that must be considered can 
make new method development an arduous process [98, 126]. Consider just the 
stationary phase: while the diverse array of commercially available columns is 
useful in providing a solution for most applications, the process of screening and 
selecting a suitable pair can quickly become formidable. 
When considering the mobile phase chemistry even minor changes in 
conditions such as pH can have a large influence on the retention behaviour of 
ionisable compounds [107]. Depending on the application, this influence can be 
very useful or detrimental to the separation [127]. Overall, possibly the most 
important consideration for 2D-HPLC is the compatibility of the two dimensions; 
otherwise physical effects such as solvent immiscibility will result, at the detriment 
to chromatographic performance [1, 2, 119, 120]. 
 A systematic approach to 2D-HPLC method development is therefore 
important, as the alternative somewhat blind approach of conducting trial and error 
separations until the analyst reaches a satisfactory result can become very 
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prolonged [111, 209]. The chromatography modelling software DryLab®, 
developed by Molnár Institute, offers a systematic in silico approach to method 
optimisation. The aim of this chapter is to use a quality by design approach to 
develop a 2D-HPLC separation for human urine with the aid of DryLab® 
modelling. Specifically, the focus will be on using DryLab® as part of a strategy 
to select the most orthogonal column pair and optimise the gradient time and 
temperature for the 2D-HPLC method. To satisfy the requirements of the software 
[136], two training separations of urine per parameter, i.e. gradient time and 
temperature, will be conducted on a selection of columns, and the changing 
retention behaviour of a number of peaks recorded. During the training separations, 
significant changes in elution order are likely to create difficulty in tracking peaks 
over the different columns under comparison. Therefore parameters other than 
gradient time and temperature will not be considered in detail, as they are easily 
optimised using DryLab® and are sufficient to achieve the aims of the chapter [27, 
189, 190].  
Ultraviolet absorbance and acidic potassium permanganate 
chemiluminescence detection have been selected to assist in tracking the changing 
retention of each peak during the training separations [207]. Following this 
DryLab® will be used to optimise each separation, and the orthogonality for every 
possible column combination will be calculated. Once the combination with the 
greatest orthogonality is selected, a 2D-HPLC separation will be developed in silico 
and applied to the human urine sample. 
Using the urine sample mixture as the reference during optimisation 
presents a number of advantages. Firstly, the method will take into account the 
complete sample, with all components and their changing interactions under 
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different retention conditions, which is not possible when using standards only. An 
extensive knowledge of each sample constituent is not required, as the differences 
in sensitivity and selectivity between the ultraviolet absorbance and acidic 
potassium permanganate chemiluminescence detection strategies will assist in peak 
matching between trial chromatograms. For instance those components which 
absorb ultraviolet radiation but do not participate in the light emitting redox 
reaction with potassium permanganate will be matched, and their peak areas 
compared to assist tracking over the trial chromatograms. Furthermore, the 
particular components that react to produce chemiluminescence with potassium 
permanganate can be identified and matched with the corresponding ultraviolet 
peak based on their retention times. Thus the information obtained from both 
detection strategies is complimentary, providing guidance for the accurate 
identification of peaks between the trial chromatograms. 
The methods developed in this chapter will be evaluated against an 
alternative approach by Bassanese and co-workers [53] whereby antioxidant 
standards were used to represent a coffee sample in the development process. In 
this approach, screening of each column was undertaken using a set of 17 
antioxidant standards, as this was considered to be an appropriate number to 
estimate the 2D-HPLC peak capacity for extrapolation to a larger number of 
components [115].   
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2. Experimental 
 
  Chemicals and reagents 
Deionised water was filtered through a 0.45 μm filter (Sigma-Aldrich Pty 
Ltd., Castle Hill, NSW, Australia) before use. HPLC grade methanol was supplied 
by Ajax Finechem Pty. Ltd. (Taren Point, NSW, Australia). Trifluoroacetic acid 
(TFA, Reagent Plus 99%) and sodium polyphosphate (crystals, +80 mesh, 96%) 
were supplied by Sigma-Aldrich (St. Louis, USA). Potassium permanganate (AR 
Grade), hydrochloric acid (32% w/w, Analytical Reagent) and formaldehyde (37%) 
were obtained from Chem Supply (Gilman, SA, Australia). Sulfuric acid (98%) was 
supplied by Merck (Kilsyth, Victoria, Australia). The permanganate reagent was 
prepared daily by dissolution of sodium polyphosphate in deionised water, adding 
potassium permanganate and adjusting to pH 2.5 using sulfuric acid. 
 
  Urine sample preparation 
Fresh urine samples were collected daily from the same subject and 
preserved by adding a 7.5 M hydrochloric acid solution (50 μL per 1 mL of urine) 
and stored at 4 °C until required. Immediately prior to analysis, the preserved 
sample was diluted 10-fold with deionised water and filtered with a 0.45 μm 
syringe filter. To reduce the effects of sample variability the four trial separations 
for each stationary phase were always performed on the same day and the urine 
stored at 4 °C between subsequent analyses.  
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  HPLC instrumentation 
An Agilent 1260 chromatograph equipped with a quaternary pump 
(incorporating a vacuum degasser), column thermostat, diode array detector and 
autosampler (Agilent Technologies, Mulgrave, Victoria, Australia). Agilent 
Chemstation software was used for system control and data acquisition.  
Chemiluminescence detection was employed after the column eluent was 
passed through the diode array detector. The exit line from the UV flow cell was 
merged with 2M aqueous formaldehyde at a T-piece, and then mixed with the acidic 
potassium permanganate reagent at a second T-piece immediately prior to entering 
a coiled-tubing detection flow cell [62]. The flow-cell was mounted flush against 
the window of a photomultiplier tube (Electron Tubes model 9828SB; ETP, NSW, 
Australia) encased in a light tight housing and powered by a stable power supply at 
900 V. The potassium permanganate chemiluminescence reagent and 
formaldehyde solution were propelled at 1 mL min-1 using two Model 12-6 Dual 
Piston Pumps (Scientific Systems, PA, USA). A Hewlett-Packard 35900E analogue 
to digital converter was used to convert detector signals (Agilent Technologies). 
 
  HPLC columns 
Thirteen reverse phase columns were chosen to investigate the in silico 
selection of a stationary phase using the chemically complex sample as the test 
mixture. The pore diameter of each of the following columns was 100 Å unless 
otherwise stated: Zorbax Eclipse AAA (150 × 4.6 mm, 3.5 μm, Agilent 
Technologies); Synergi Hydro-RP (250 × 4.6 mm, 4 μm, 80 Å pore diameter, 
Phenomenex, Lane Cove, NSW, Australia); C18 XDB (150 × 4.6 mm, 5 μm, 
Agilent); Poroshell EC-C18 (100 × 4.6 mm, 2.7 μm, Agilent); Poroshell EC-CN 
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(100 × 4.6 mm, 2.7 μm, Agilent), Poroshell EC-C18 (50 × 4.6 mm, 2.7 μm, 
Agilent); Poroshell EC-C8 (100 × 4.6 mm, 2.7 μm, Agilent); Synergi Polar-RP (150 
× 2 mm, 4 μm, 80 Å pore diameter, Phenomenex), Aqua C18 (150 × 2.0 mm, 3 μm, 
125 Å pore diameter, Phenomenex), Luna NH2 (150 × 4.6 mm, 5 μm, 
Phenomenex), Aqua C18 (150 × 2.0 mm, 5 μm, 200 Å pore diameter, 
Phenomenex); Phenyl XDB Eclipse (150 × 4.6 mm, 3.5 μm, Agilent); and 
Chromolith Performance RP 18e (100 × 3 mm, Merck, Kilsyth, Victoria, 
Australia). 
 
  HPLC simulation protocol 
Retention parameters for matched HPLC peaks (2 gradient times at 2 
temperatures) were entered into DryLab® (Molnar-Institute for applied 
chromatography, Berlin, Germany). To compare selectivity performance of the 
different HPLC columns, and remove retention time as a factor, the temperature 
and linear gradient times were optimised so that the last eluted compound had a 
retention factor of approximately 10. Following optimisation, each column was 
compared via the Gilar fractional surface coverage (bins) method [107, 115] using 
a Mathematica 9.0 notebook (distributed by Hearn Scientific, South Yarra, 
Victoria, Australia) developed in-house. The two columns that had the greatest 
orthogonality when paired were judged to be the optimal for 2D-HPLC. Instances 
where multiple combinations were deemed optimal were resolved using visual 
examination. 
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  One-dimensional HPLC methods 
Single injections of the urine matrix on each respective column were made 
to fulfil the requirements of DryLab®. The separations were carried out using an 
aqueous methanol gradient under the following conditions: Run 1 a 20-min gradient 
at 30 °C, Run 2 a 60 min gradient at 30 °C, Run 3 a 20-min gradient at 45 °C and 
Run 4 a 60-min gradient at 45 °C. The mobile phase gradients had an initial 
composition of 5% methanol that increased to 100% over the specified gradient 
time. All experiments were operated at a flow rate of 1 mL min-1, and an injection 
volume of 20 μL was used. Columns were thermally equilibrated for 1 hr when the 
temperature was changed, and trifluoroacetic acid was added to all mobile phases 
at a concentration of 0.1% v/v prior to analysis. 
 
  Two-dimensional HPLC methods 
To control the second dimension injection solvent composition, a counter gradient 
was combined with the first dimension eluent through a T-piece [52]. The 
conditions for the counter gradients were calculated according to previous work by 
Snyder and co-workers [210]. The 2D-HPLC separation of urine was performed in 
the off-line mode with the Synergi Polar-RP column in the first dimension and 
Poroshell Cyano column in the second. A 100 μL urine injection on the first 
dimension was separated via a linear gradient, which began with an initial 
concentration of 5% methanol and increased to 100% over 20 min at a flow rate of 
0.5 mL min-1 and column temperature of 20 °C. A Gilson FC204 fraction collector 
(John Morris Scientific, Balwyn, Victoria, Australia) was used to collect fractions 
at 0.09 min intervals that corresponded to 3 fractions peak-1. Each fraction was 
merged with a counter gradient operating from 10% methanol to 0% methanol, at 
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a flow rate of 4.75 mL min-1, prior to the fraction collector. The counter gradient 
adjusted the eluent composition (and thus the second dimension injection solvent) 
to 10% methanol. A 100 μL sample of each fraction was then injected onto the 
second dimension and separated with a 10 min linear mobile phase gradient from 
10% methanol to 100%, using a flow rate of 1.5 mL min-1 and a column temperature 
of 60 °C. A minimum of 3 column volumes of mobile phase was used for 
re- equilibration between subsequent analyses.  
 Two-dimensional chromatographic data recorded by ChemStation was then 
imported to Wolfram Mathematica 10 (distributed by Hearn Scientific Software, 
Melbourne, Victoria, Australia) and converted to two-dimensional surface plots, 
which distinguish peaks of different intensities using a hot to cold colour gradient 
[198].   
Chapter Six 
134 
 
3. Results and Discussion 
 
  Stationary phase screening using a human urine sample matrix 
Human urine was selected as the test sample for this chapter as it represents 
a chemically complex sample of medical interest, is readily available and is 
relatively easy to obtain [3]. The first step in method development was to select two 
appropriate stationary phases for the 2D-HPLC separation. Trial separations of 
urine were initially conducted on thirteen different columns, which were carefully 
selected to represent those commercially available formats with appropriate 
selectivity for this application. To generate sufficient data to rank the orthogonality 
of each stationary phase combination, four DryLab® retention time inputs per peak 
were collected per column, to yield a total of 52 injections. The four retention inputs 
were comprised of a minimum and maximum operating value pertaining to both 
gradient time and temperature.  
Gradient times of 20 min and 60 min were used for each column over the 
range of 5% to 100% methanol to train DryLab® with a broad design space for 
modelling [136]. The two temperatures trialled at each gradient time were 30 °C 
and 45 °C, as they both fell within the operating range of the 13 columns. Thus the 
four retention inputs per peak were generated from the following training runs- 
Input 1: 20 min gradient at 30 °C; Input 2: 60 min gradient at 30 °C; Input 3: 20 min 
gradient at 45 °C and Input 4: 60 min gradient at 45 °C. Figure 6.1 shows the 
training separations conducted using the Synergi Hydro-RP column.  
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 (a)       (b) 
 
 
(c)       (d) 
 
Figure 6.1: Four trial separations of urine on a Synergi Hydro-RP column with UV 
absorbance and permanganate chemiluminescence detection. (a) 20 min gradient, 
30 °C, (b) 20 min gradient,  60 °C, (c) 60 min gradient, 20 °C and (d) 60 min 
gradient at 60 °C.  
In each case the UV absorbance baseline is scaled to 0 mAu on the response axis 
and the chemiluminescence signal is scaled to 225 mAu. The relative peak heights 
and areas were compared between the detection methods for each trial to identify 
the likely candidates for peak matching.  
Baselines were corrected with using an asymmetric least squares approach (λ = 1, 
p = 1.0 × 10-7) [36].  
 
 In lieu of standards and identified sample components the retention times 
of compounds within the sample required matching over the 52 injections. Whilst 
DryLab® has inbuilt peak matching capability which functions by comparing peak 
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areas from recorded chromatograms it was unable to distinguish between co-eluting 
peaks and did not reliably track changes in elution order due to the complexity of 
the urine sample. Therefore a manual approach was adopted, by comparing the 
relative ratios of peak areas between ultraviolet absorbance and potassium 
permanganate chemiluminescence detection. Using the two detection 
methodologies increased the confidence with which the peaks were matched, as 
they were selective to different attributes of the sample constituents.  
Even when using data from the two detection methods, tracking each peak 
over the 52 training injections proved to be difficult and time consuming. Retention 
times for a total of seven compounds were confidently matched over 32 of the 
training chromatograms by comparing the relative heights and area ratios of peaks 
between the two detection strategies on the different columns. The retention times 
of the seven peaks on the remaining 20 training runs (five columns) could not be 
matched with confidence, therefore these were removed from the stationary phase 
comparison. 
 
 Determination of the stationary phase pair with the highest 
orthogonality 
 According to Gilar et al. [115], at least 25 data points are required to 
accurately extrapolate the final orthogonality of a 2D-HPLC separation using the 
fractional surface coverage (bins) method. Although the number of peaks detected 
and matched between chromatograms was much less than this, the bins approach 
was still used to rank orthogonality of the columns. The ranking was conducted by 
entering the matched retention data from each column into DryLab® and 
remodelling each separation, so the last eluting peak a retention factor (k’) of 
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approximately 10. The temperature was then adjusted to provide the largest 
minimum peak resolution between adjacent peaks, and this remodelled retention 
data used to calculate orthogonality. For example, Figure 6.2 shows the DryLab® 
modelled chromatogram of the seven matched urine peaks for the Synergi 
Hydro- RP column. The orthogonality values which were then calculated for each 
of the column pairs from the modelled chromatograms are shown in Table 6.1, 
using the bins approach by Gilar and co-workers [107, 115] detailed in Chapter 
One. 
 
Figure 6.2: Representative optimised separation of the seven matched sample 
peaks, on the Synergi Hydro-RP column. DryLab® simulation software was used 
to adjust the separation so the last eluting peak had a retention factor of 
approximately 10 and modify the temperature to provide the largest minimum peak 
resolution between adjacent peaks.  
 Retention times from the optimised chromatograms were then compared 
between stationary phases, using the bins method to identify the column pairs with 
highest orthogonality.  
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Table 6.1: Orthogonality (%) prediction of the 2D-HPLC separation performance 
using urine on each column combination. The combinations with the highest 
predicted orthogonality values are underlined. 
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Synergi Hydro-RP  35 18 18 0 18 18 18 
Poroshell C18   18 18 18 18 18 18 
Synergi Polar-RP    35 18 18 18 0 
Poroshell CN     18 18 18 18 
Poroshell C8      18 0 18 
C18 XDB Eclipse       0 18 
Short Poroshell C18 + Poroshell 
CN        18 
Short Poroshell C18         
 
 The highest predicted orthogonality values are shared by both the Synergi 
Hydro-RP × C18, and the Synergi Polar-RP × CN column combinations. Every 
other pair analysed had an orthogonality value of 18% or 0%. The similarities in 
the orthogonality data can be explained by the limitation of only 7 peaks available 
for the comparison. The fewer peaks increased the size of each bin compared to 
when more data is present, which in turn increased the likelihood of the bins being 
occupied. After a visual inspection of the data from the two pairs with 35% 
orthogonality it was decided that the combination of Synergi Polar-RP × CN would 
be used as the optimal column combination for the two- dimensional separation.
 
  Coupling the selected stationary phases for 2D-HPLC 
 After selecting the Synergi Polar-RP × CN combination the DryLab® 
software was again employed, this time to optimise the separation on each column 
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in silico, prior to coupling them for 2D-HPLC.  The inbuilt resolution heat map 
shown in Figure 6.3 was used as a starting point to select the optimal gradient time 
and temperature for the method.  
(a)  
 
 
(b)  
 
        Resolution range between closest eluting peak pair (maximum to minimum) 
Figure 6.3: (a) The inbuilt two- dimension DryLab® resolution map, generated 
from the resolution of peaks identified in the urine samples using the first 
dimension Synergi Polar-RP column. This resolution map illustrates gradient and 
temperature dependent resolution for reverse phase HPLC. (b) The resolution 
colour scale shows the maximum and minimum resolution that can be achieved 
between the closest eluting pair of compounds under these conditions [130]. 
 
 Whilst the conditions within the red shaded region give the best resolution 
between the closest eluting peak pair, the orange and yellow zones are also 
important to consider as they extend the scope to select practical conditions for 
method development. The resolution map was utilised to model a separation 
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fulfilling the main criteria of a peak width sufficient to collect 3 fractions peak-1, 
the optimal sampling frequency according to the Murphy-Schure-Foley 
recommendation [109]. For the second dimension, DryLab® was used to simulate 
a method that balanced resolution with run time, a factor which has a significant 
influence on the overall time required for analysis in 2D-HPLC. The methods 
developed in silico were then tested by separating a urine sample on each column 
in the one dimensional analysis mode (Figure 6.4). 
 Solvent compatibility was the final factor to consider before coupling the 
first and second dimensions. As detailed in the introductory chapter of this thesis, 
solvent mismatch is a major contributor to poor separation efficiency in 2D-HPLC. 
To ensure the fractions transferred between the first and second dimensions in this 
method are compatible, a counter gradient was merged at a T-piece with the eluent 
from the initial separation [52]. The counter gradient was simulated to ensure each 
fraction from the first dimension had a final methanol composition of 10% (Figure 
6.5). Therefore, each fraction injected into the second dimension had a solvent 
composition identical to the initial gradient conditions.  
However, using a counter gradient is expected to lower the final 
orthogonality of the separation from the predicted value [53]. This is a result of 
increasing the starting point of the second dimension methanol gradient to 10% 
from the 5% used in the earlier simulations, which is necessary due to the limited 
maximum flow rate of the counter gradient [52, 53]. 
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(a)  
 
(b)  
 
 
Figure 6.4: Single dimension separations of urine using the methods simulated 
with DryLab® for 2D-HPLC. (a) Synergi Polar-RP and (b) cyano stationary 
phases. 
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Figure 6.5: Simulated counter gradient conditions used to deliver a final eluent 
composition of 10% methanol for all fractions from the first dimension. The blue 
line represents the gradient of the first dimension (flow rate 0.5 mL min-1), the 
dotted red line indicates the final eluent composition (10% methanol) of each 
fraction, and the purple line indicates the counter gradient (flow rate 4.75 ml min-
1). 
 
 At this point, the 2D-HPLC separation of urine was ready to carry out in the 
off-line heart cutting mode. Fractions of the first dimension (Synergi Polar-RP) 
were merged with the counter gradient, and collected every 0.1 min. Each fraction 
was then loaded into the autosampler and injected into the second dimension in the 
order in which they were collected. Presented in Figure 6.6 is the surface plot of 
the 2D-HPLC urine separation.  
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Figure 6.6: Surface plot of the two- dimensional HPLC separation of urine, with a 
Synergi Polar-RP column in the first dimension and cyano in the second, recorded 
with a UV detector at 230 nm. White dots represent peak maxima as detected using 
peak picking algorithms [211]. Peak of different intensities are represented by a hot 
to cold colour gradient. 
 
 Peak picking algorithms [211] were used to determine retention times of 
peaks from the 2D-HPLC separation. A total of 56 peaks were identified and used 
to calculate the final orthogonality of 30%, via the bins method. This value is in 
closer than expected agreement with the predicted value of 35%, considering only 
7 peaks were matched between the trial chromatograms. As previously mentioned 
the counter gradient was expected to reduce the final orthogonality from the 
predicted value. Furthermore, it is likely that if more peaks could be matched 
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between the separation trials, the final orthogonality value would be even closer to 
the prediction. However matching more peaks in a sample as chemically complex 
as urine would require the use of mass spectrometry and an efficient approach to 
sifting through the slew of resulting data. 
 
  A comparison of in silico 2D-HPLC method development using a 
sample vs. standards 
 The work presented in this chapter is part of a two-part study utilising in 
silico 2D-HPLC method development [53]. Whilst the second part of the study was 
not undertaken as a part of this thesis, the results are worth highlighting for 
comparative purposes. Part 2 of the study utilised seventeen antioxidant standards 
to model the sample and develop a 2D-HPLC separation of coffee.  
 Using the standards eliminated the difficult and time consuming task of 
matching peaks over the 52 initial separations that were used to rank column 
orthogonality. However, relying on the standards does not accurately represent the 
actual chemically complexity sample, especially if its composition is largely 
unknown. Furthermore, the standards required a significantly greater amount of 
instrument time to generate the retention time input data for DryLab®, with a total 
of 1,292 injections over ten stationary phases (compared to only 40 injections for 
the sample).  
 The predicted and final orthogonality values were closer when the standards 
were used, with respective values of 38% and 39%, compared to 35% and 30% 
using the sample. Whilst both parts of the study were successful for predicting the 
final separation outcome, they required a significant time investment, and thus may 
only be useful in 2D-HPLC method design for repeat analysis.   
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4. Conclusions 
 DryLab® chromatography modelling software was used to compare the 
influence of gradient time and temperature on the separation of human urine, over 
a total of 13 columns. This comparison was then used to determine the most 
orthogonal column pair to use for a 2D-HPLC method. Matching peaks over the 52 
trial injections proved to be time consuming and uncertain, even with the selectivity 
of two different detection strategies. In the end a total of seven peaks were matched 
over eight of the columns, and the bins method used to calculate orthogonality of 
each pair. The Synergi Polar-RP × CN pair had the equal highest predicted 
orthogonality values of 35% and were selected. DryLab® was then used to simulate 
the separations on each individual dimension, and together with a counter gradient 
to control the fraction composition, a 2D-HPLC separation was developed. The 
final orthogonality value of 30% was similar to the prediction, however the 
successful match of more peaks is required to increase the accuracy of the in silico 
modelling.  
 This chapter represented the first of a two part study using DryLab® as a 
tool for in silico 2D-HPLC method development. The second part of the study, 
using a set of standards to model the sample required a significantly larger number 
of trial injections to satisfy the requirements of the HPLC simulator. However 
tracking the retention times of peaks was more straightforward and certain, 
resulting in an orthogonality closer to the final outcome (predicted = 38%; actual = 
39%). Despite the greater accuracy in peak matching, the co-elution and changing 
retention behaviour of the complex sample matrix components are not considered 
during modelling. 
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The work presented in this chapter is published as: D.N. Bassanese*, B.J. 
Holland*, X.A. Conlan, P.S. Francis, N.W. Barnett, P.G. Stevenson, ‘Protocols for 
finding the most orthogonal dimensions for two-dimensional high performance 
liquid chromatography’, Talanta, 134 (2015) 402-408. *Co-first authors
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Chapter Seven 
 
Future work 
 
 A detailed study into the important characteristics of sodium 
polyphosphates for the enhancement of acidic potassium permanganate 
chemiluminescence is presented in Chapter Three of this thesis. Whilst a number 
of requisite properties for the bulk materials were found, the identity of the exact 
phosphate oligomer(s) that complex with excited manganese species is still elusive. 
Undertaking a direct comparison of polyphosphate separation with and without 
added manganese species using ion chromatography coupled with ICP-MS is 
suggested to pursue further knowledge regarding the polyphosphate oligomer(s) 
involved. Furthermore the research presented in Chapter Three could be utilised to 
to further the understanding of the role polyphosphate chain length has in the 
lifetime of the excited manganese species. This could be achieved by conducting 
image analysis of the photographed chemiluminescence presented in Figure 3.3 to 
show how intensity changes with distance from reagent and analyte mixing within 
the flow cell.  
 Chapter Four of this thesis outlined the development of a one- dimensional 
HPLC separation for quantification of neurotransmitter levels in rat brain and a 2D-
HPLC method for the analysis of their metabolites in urine. To follow up the one-
dimensional separation needs to be applied to a larger sample set (n ൒ 7) to further 
understand the variation observed between individual rats. Additionally the 
sensitivity and surface coverage of the 2D-HPLC separation could be improved by 
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adopting the method development protocol presented in Chapters Five and Six of 
this thesis to ensure the optimal column and solvent system is employed. 
 Chapter Five of this thesis explored a number of practical approaches to 
circumventing the problems which arise from the injection of comparatively strong 
solvent fractions into the second dimension of a typical RP × RP 2D-HPLC 
separation. The first approach of adding polar solutes to the solvent fraction was 
ineffective in this instance, however the use of salting out salts [200] should be 
investigated before fully disregarding this method. An alternative stratagem 
conversely was successful in the adoption of temperature programming for the first 
dimension of a 2D-HPLC urine separation. Whilst temperature programming was 
beneficial a follow up study is recommended to quantify the gain in resolution, peak 
shape and peak capacity.  
 The real improvements in the benefits of temperature programming 
however can be realised by overcoming many key design limitations in current 
HPLC heating equipment which are not designed for this application. In particular, 
if these units can be designed to be more responsive to temperature change and 
more efficient at heating columns significant time could be saved. Similarly, 
enhanced cooling and re-equilibration could be achieved by integration of an 
effective and controllable heat sink. 
 Chapter Six presents the application of chromatography modelling software 
DryLab® to aid in the development and optimisation of 2D-HPLC methods. Using 
a complex sample for the trial separations to generate the DryLab® input data 
proved to be a laborious and time consuming task of manually matching peaks 
using the UV and chemiluminescence signals. The required time and accuracy of 
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peak identification could be made more favourable by the use of a mass 
spectrometer for development of an automated approach to compute the data before 
inputting to DryLab®. This would allow for a more comprehensive method 
optimisation procedure that could consider additional variables such as solvent and 
pH conditions used in the separation. 
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